Healthcare News Releases

Air Products au Congrès de Pneumologie de Lyon

Wed, 25 Jan 2012 00:00:00 -0500

La Division médicale d’Air Products est au service des professionnels de la santé (en milieu hospitalier comme dans le secteur privé ou associatif) depuis plus de 20 ans en France. Son expertise technique en matière d’installations et son offre alliant sécurité et confort d’utilisation en font un partenaire de choix des prestataires en oxygénothérapie. C’est donc en toute logique qu’il participe au Congrès de Pneumologie organisé à Lyon du 27 au 29 janvier 2012*.

Grâce à une maîtrise technique totale des installations gaz acquise en milieu industriel et à sa connaissance du milieu médical, la division médicale d’Air Products est en mesure d’offrir aux prestataires en oxygénothérapie à domicile une réponse sur mesure à leurs attentes. Son objectif : agir en véritable partenaire afin que ces derniers puissent se concentrer sur le service à apporter à leurs patients, en toute sécurité. Après l’analyse des besoins de l’entreprise, la définition du type d’approvisionnement adapté à son mode de fonctionnement comme à son niveau de consommation, et enfin la rédaction d’un cahier des charges, Air Products fournit à ses clients l’ensemble des documents administratifs nécessaires incluant un plan de masse, avant réalisation des installations et mise en place des nourrices. Air Products prend également en charge la formation du personnel. Son service de télésurveillance est ensuite là pour prévenir toute rupture d’approvisionnement.

Air Products est présent aux côtés du prestataire chez le patient, via sa bouteille d’oxygène médical Evasion, mise au point pour faciliter la vie du personnel soignant comme le confort de l’utilisateur. Ultra-légère pour favoriser la mobilité du patient, cette bouteille en aluminium dispose également d’un système d’attache au lit rétractable avec manomètre actif bien visible. La bouteille Evasion allie simplicité d’utilisation et sécurité. Un revêtement polyuréthane transparent, spécifiquement mis au point par Air Products, a été apposé sur la bouteille,lui garantissant une protection optimale et une meilleure visibilité de son étiquetage.

La sécurité est d’ailleurs au cœur des préoccupations d’Air Products et, a fortiori, de sa division médicale. « La vie est votre métier, l’air est le nôtre » est sa devise. Concrètement, cela signifie que l’équipe médicale d’Air Products veille avec la plus grande vigilance à la stricte conformité de ses installations en gaz avec les normes sécurité les plus sévères, sans aucun compromis. C’est sans doute pour cela que plusieurs CHU aux 4 coins de la France et de nombreux clients dans le privé comme dans l’associatif lui font confiance.

Et parce qu’Air Products a toujours à cœur de mieux servir ses clients professionnels, et donc leurs patients, la société a investi et continue d’investir pour renforcer sa couverture géographique en France. C’est la raison pour laquelle elle a acquis l’entreprise familiale SAGA et sa filiale SAGA médicale en novembre 2010 consolidant sa présence dans les régions Centre et Sud-Ouest et qu’elle disposera d’une quatrième source d’oxygène médicale agréée d’ici l’été dans l’ouest de la France.

NOTE: This release may contain forward-looking statements within the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. These forward-looking statements are based on management’s reasonable expectations and assumptions as of the date of this release regarding important risk factors. Actual performance and financial results may differ materially from projections and estimates expressed in the forward-looking statements because of many factors not anticipated by management, including risk factors described in the Company’s Form 10K for its fiscal year ended September 30, 2011.

A propos d’Air Products
Air Products (NYSE : APD) sert des clients dans l'industrie, l'énergie, la technologie et la santé à travers le monde entier grâce à un portefeuille unique de gaz de l'air, gaz de procédés et gaz spéciaux, de produits chimiques, d'équipements et de services. Fondé en 1940, Air Products a su prendre une place prépondérante sur des marchés clés comme les matériaux semi-conducteurs, l'hydrogène de raffinerie, les services de soins médicaux à domicile, la liquéfaction du gaz naturel ainsi que les revêtements et adhésifs issus de technologies de pointe. Le Groupe est reconnu pour sa culture de l'innovation, son excellence opérationnelle et son souci permanent de la sécurité et de l'environnement. Air Products a réalisé un CA mondial de 10,1 milliards de dollars pendant l'exercice fiscal 2011, est présent dans plus de 40 pays et emploie 18 900 personnes à travers le monde.

Air Products est actif dans plus de 15 pays en Europe. En France, Air Products est issu de la fusion de Prodair et de l'Oxygène liquide en 1990. Aujourd'hui, Air Products est le 2e plus grand producteur de gaz industriels en France et détient 15 % de parts de marché. En France, Air Products dispose de nombreux dépôts et sites de production et sert sa clientèle par l'intermédiaire d'un réseau étendu d'agents et de son service Gas Taxi. Pour plus d’informations, rendez-vous sur www.airproducts.fr.

Air Products annonce son projet de cession au Groupe Linde de ses activites de soins medicaux a domicile (Homecare) en Europe Continentale

Mon, 09 Jan 2012 00:00:00 -0500

Air Products (NYSE : APD) a annoncé la conclusion d’accords avec le groupe Linde portant sur le rachat de ses activités de soins médicaux à domicile (Homecare) en Europe continentale. Il s’agit pour Linde d'acquérir les activités Homecare de l'entreprise en Belgique, en Allemagne, au Portugal et en Espagne ainsi qu’en France. Les transactions sont assujetties aux procédures d'approbation réglementaire et de consultation des employés.

Le prix d'achat total des activités de soins médicaux à domicile (Homecare) d'Air Products en Europe continentale sera de 590 MM €, sous réserve des conditions convenues lors de la signature du contrat.

Les termes de ces accords couvrent la vente des services aux patients d’Air Products en oxygénothérapie, traitement de l’apnée du sommeil et thérapie par perfusion en Europe continentale. Ces activités concernent près de 260 000 patients au total, répartis dans les cinq pays cités précédemment et ont représenté un CA de 210 MM d’euros en 2011.

John McGlade, président et PDG de l'entreprise, a déclaré : « Pendant de nombreuses années, notre équipe européenne de soins médicaux à domicile (Homecare) a géré ces activités de façon très rentable et nous a permis de nous imposer comme leader dans divers domaines. Mais, de plus en plus, la tendance a consisté à privilégier les concentrateurs au détriment des bouteilles, tandis que les thérapies autres que l'oxygénothérapie connaissent une croissance accélérée en Europe continentale. Par conséquent, nous pensons que ces activités ne sont plus en accord avec nos activités principales dans le secteur des gaz.”

“Notre stratégie de croissance vise les marchés de l'énergie, de l'environnement et les marchés émergents, pour lesquels nous continuons de percevoir de nouvelles opportunités. Nous restons concentrés sur notre réussite dans ces domaines en continuant de favoriser la recherche et le développement, les technologies et les investisssement de capitaux chez Air Products. »

« Malgré la situation économique, la France reste l'une des plus grandes économies mondiales et un marché important à nos yeux », a commenté Graham Rhodes, vice-président régional Global Merchant Gases Strategy and Business Development (Stratégie internationale gaz industriels et Développement commercial). « Notre engagement est clair et cela a été démontré par l'acquisition l'année dernière d'une participation majoritaire dans l'entreprise française SAGA, qui a renforcé notre position dans les régions du centre et du sud-ouest du pays. »

L'entreprise évalue actuellement différentes options pour les intérêts qui lui restent dans le secteur des soins médicaux à domicile (Homecare) au Royaume-Uni et en Irlande, ainsi qu'en Argentine et au Brésil. Air Products continuera à diriger ces activités dans le cadre de son portefeuille , décidé à gagner de nouvelles parts de marché et à fournir des soins de qualité aux patients. De façon plus générale, les activités liées à la santé (Healthcare) continuent à offrir des opportunités rentables grâce à la fourniture de gaz industriels et de services associés aux hôpitaux et autres prestataires de soins.

A propos d’Air Products :
Air Products (NYSE : APD) sert des clients dans l’industrie, l’énergie, la technologie et la santé à travers le monde entier grâce à un portefeuille unique de gaz de l’air, gaz de procédés et gaz spéciaux, de produits chimiques, d’équipements et de services. Fondé en 1940, Air Products a su prendre une place prépondérante sur des marchés clés comme les matériaux semi-conducteurs, l'hydrogène de raffinerie, les services de soins médicaux à domicile, la liquéfaction du gaz naturel ainsi que les revêtements et adhésifs issus de technologies de pointe. Le Groupe est reconnu pour sa culture de l’innovation, son excellence opérationnelle et son souci permanent de la sécurité et de l’environnement. Air Products a réalisé un CA mondial de 10,1 milliards de dollars pendant l'exercice fiscal 2011, est présent dans plus de 40 pays et emploie 18 900 personnes à travers le monde.

Air Products est actif dans plus de 15 pays en Europe. En France, Air Products est issu de la fusion de Prodair et de l'Oxygène liquide en 1990. Aujourd'hui, Air Products est le 2e plus grand producteur de gaz industriels en France et détient 15 % de parts de marché. En France, Air Products dispose de nombreux dépôts et sites de production et sert sa clientèle par l'intermédiaire d'un réseau étendu d'agents et de son service Gas Taxi.

NOTE: This release may contain forward-looking statements within the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. These forward-looking statements are based on management’s reasonable expectations and assumptions as of the date of this release regarding important risk factors. Actual performance and financial results may differ materially from projections and estimates expressed in the forward-looking statements because of many factors not anticipated by management, including risk factors described in the Company’s Form 10K for its fiscal year ended September 30, 2011.

Air Products anuncia sus planes de venta de la división de terapias domiciliarias en Europa Continental a Linde

Mon, 09 Jan 2012 00:00:00 -0500

La compañía Air Products ha anunciado hoy el establecimiento de un acuerdo con Linde (The Linde Group) para la compra de su negocio de terapias domiciliarias en Bélgica, Francia, Alemania, España y Portugal. Dicha transacción está sujeta, a día de hoy, a los requisitos de aprobación legislativa, así como a la consulta de los empleados.

El precio total de la compra de la división de atención domiciliaria de Air Products asciende a 590 millones de euros, sujeto a los términos acordados tras la finalización de la transacción.

Los acuerdos cubren tanto la venta de los servicios de terapias domiciliarias de Air Products (oxigenoterapia, terapia del sueño, aerosolterapia, etc.), como la de otros servicios de la compañía en los cinco países antes mencionados, que atienden a más de 260.000 pacientes.

Según apunta John McGlade, presidente y director general de Air Products, “durante muchos años, nuestro equipo europeo de terapias domiciliarias ha dirigido con éxito esta división y, además, ha conseguido que alcance posiciones de liderazgo. Pero la tendencia de este mercado hacia los concentradores y el rápido incremento en Europa de terapias respiratorias que no precisan gases, hace que creamos que este negocio tiene cada vez menos sinergias con nuestro negocio principal, centrado en los gases”. “Nuestra estrategia actual de crecimiento se basa en nuevas oportunidades en el campo de la energía, medio ambiente y mercados emergentes en los que vemos importantes oportunidades de desarrollo”.

Por su parte, Grahan Rhodes, vicepresidente regional de Desarrollo Empresarial y Estratégico de Global Merchant Gases, apunta que “España es y seguirá siendo un mercado importante para la Compañía. De hecho, el pasado noviembre se anunció una importante inversión en una nueva unidad de separación de gases del aire en Sagunto (Valencia) para abastecer la creciente demanda de nuestros clientes”.

“En el ámbito estratégico, en España están implantadas algunas de nuestras actividades principales, como son los laboratorios, básicos para el trabajo en I+D, o el Centro de Servicios Compartidos de Cornellá que, tras una inversión hace unos años de aproximadamente 8 millones de euros, ahora alberga las funciones corporativas administrativas, financieras y de asistencia al cliente, con servicio para 12 países en toda Europa”, continúa explicando Grahan Rhodes.

Tras este acuerdo, la empresa está valorando varias opciones relacionadas con el resto de sus áreas de negocio en el sector de las terapias domiciliarias en el Reino Unido e Irlanda, así como en Argentina y Brasil. Air Products seguirá contando con estas divisiones como parte de su cartera de servicios, compitiendo para ganar nuevas oportunidades de negocio y proporcionando una atención de calidad a los pacientes. Desde un punto de vista más amplio, el sector sanitario sigue proporcionando oportunidades ventajosas como el suministro de gases medicinales y servicios relacionados con hospitales y otros proveedores del sector médico.

Sobre Grupo Air Products
Air Products (NYSE:APD) surte a los mercados industrial, energético, tecnológico y sanitario con una cartera única de gases atmosféricos, gases de proceso y especiales, materiales de alto rendimiento y equipos y servicios.

Fundada en 1940, Air Products es líder en mercados clave como semiconductores, refinería de hidrógeno, servicios de asistencia sanitaria, licuefacción de gas natural y recubrimientos avanzados y adhesivos. La compañía es reconocida por su cultura innovadora, su excelencia operacional y su compromiso con la seguridad y el medioambiente. En el ejercicio de 2011, Air Products obtuvo unos ingresos de 10.100 millones de dólares, con actividades en más de 40 países y 18.900 empleados en todo el mundo. Más información en www.airproducts.com.

Para más información:
BURSON-MARSTELLER
Tel: 93.201.10.28
Izaskun Martínez: izaskun.martinez@bm.com
Gloria Almirall: gloria.almirall@bm.com

A Air Products anuncia plano de venda do negócio de Cuidados Domiciliários na Europa Continental ao grupo Linde

Mon, 09 Jan 2012 00:00:00 -0500

A Air Products (NYSE: APD) anunciou hoje que chegou a acordo com o grupo Linde acerca da venda do negócio de Cuidados Domiciliários na Bélgica, França, Alemanha, Portugal e Espanha. As transações estão sujeitas a requisitos de aprovação legal e de consulta dos funcionários.

O preço total da aquisição do negócio de Cuidados Domiciliários na Europa Continental da Air Products será de € 590 MM (sujeito aos termos acordados aquando da sua conclusão).

O acordo inclui a venda dos serviços para pacientes de terapia com oxigénio, terapia do sono e terapia de infusão da Air Products na Europa Continental. Este negócio abrange cerca de 260 mil pacientes, num total de cinco países, onde obteve uma receita aproximada de € 210 MM no ano passado.

John McGlade, Chairman, President e CEO, comentou: “Ao longo dos anos, a nossa equipa de Cuidados Domiciliários na Europa Continental desenvolveu um negócio de sucesso, ajudando-nos a conseguir várias posições de liderança. No entanto, com as mais recentes tendências dos concentradores e terapias sem oxigénio, acreditamos que esta área já se afastou do nosso negócio central de gases.”

A nossa estratégia de crescimento baseia-se nos mercados energéticos, ambientais e emergentes, onde continuarmos a detetar oportunidades de relevo.

“Portugal é e continuará a ser um mercado importante para nós. Temos instalações de produção e enchimento em Perafita e no Cacém, o que nos permite garantir uma posição de apoio ao nosso negócio de gases central e à nossa estratégia de crescimento”, comentou Graham Rhodes, vice-presidente regional de Global Merchant Gases Strategy e Business Development.

A empresa está a avaliar as diversas opções relativamente ao seu interesse nos negócios de Cuidados Domiciliários restantes, localizados no Reino Unido e Irlanda, Argentina e Brasil. A Air Products continuará a operar estes negócios como parte da sua carteira de produtos, competindo para ganhar novos negócios e proporcionar um serviço de qualidade de cuidado de pacientes. De uma forma geral, o negócio de Healthcare continua a oferecer oportunidades vantajosas através do fornecimento de Merchant Gases e de serviços relacionados com hospitais e outros prestadores de cuidados.

Nota:
Este comunicado pode conter declarações prospetivas no âmbito das disposições contidas na Lei de Reforma de Litígio de Títulos Privados de 1995. Estas declarações prospetivas são baseadas em razoáveis expectativas da administração nesta data, atendendo aos importantes fatores de risco. O atual desempenho e os resultados financeiros podem diferir materialmente as projeções e estimativas expressas nas declarações prospetivas devido aos muitos fatores não previstos pela administração, incluindo os fatores de risco descritos no formulário 10K da empresa relativo ao ano fiscal encerrado em setembro de 2011.

Notas para os Editores:

Acerca da Air Products
A Air Products (NYSE:APD) trabalha com clientes nos mercados industrial, energético, tecnológico e de cuidados de saúde em todo o mundo, oferecendo uma carteira exclusiva de gases atmosféricos, gases de processamento e especialidade, materiais de desempenho, equipamentos e serviços. Fundada em 1940, a Air Products conquistou lugares de destaque em mercados de crescimento chave, como os materiais semicondutores, as refinarias de hidrogénio, os cuidados de saúde ao domicílio, a liquefação de gás natural e os revestimentos e adesivos avançados. A empresa é conhecida pela sua cultura de inovação, excelência operacional e compromisso com a segurança e o ambiente. No ano fiscal de 2011, a Air Products registou receitas no valor de 10,1 mil milhões de dólares, com operações em mais de 40 países e 18 900 colaboradores em todo o mundo. Para mais informações, visite www.airproducts.com.

Para mais informações poderá contactar:
Renato Póvoas
Tel: (+351) 21 844 63 91)
Email: rpovoas@guesswhatpr.com

Air Products kondigt aan om haar Homecare activiteiten in continentaal Europa te verkopen aan de Linde Group

Mon, 09 Jan 2012 00:00:00 -0500

Air Products (NYSE:APD) kondigt vandaag aan dat het met de Linde Group een overeenkomst heeft bereikt om haar Homecare activiteiten in België, Duitsland, Frankrijk, Portugal en Spanje aan deze groep te verkopen. De transacties moeten goedgekeurd worden door de regelgevende instanties en vereisen ook nog het nodige werknemersoverleg.

De totale verkoopprijs van de Homecare activiteiten van Air Products op het Europese vasteland bedraagt €590 miljoen. Die som kan schommelen naargelang de voorwaarden bij de afronding.

De overeenkomsten hebben betrekking op de verkoop van Air Products’ zuurstoftherapie, slaaptherapie en infuustherapie voor medische thuishulp in continentaal Europa. Deze activiteit bedient een 260.000 patiënten verspreid over de vijf landen en was goed voor een omzet van ongeveer €210 miljoen in 2011.

Voorzitter en CEO, John McGlade verklaart: “Ons Homecare team op het Europese vasteland is al jarenlang succesvol bezig en heeft ons geholpen om verschillende leidersposities uit te bouwen. Door de recente trend om meer gebruik te maken van zuurstofconcentratoren en therapieën die geen zuurstof gebruiken, vinden we dat Homecare activiteiten niet meer natuurlijk aansluiten bij onze kernactiviteit: gassen. Onze groeistrategie steunt op de energie-, de milieu- en de opkomende markten waarin we prachtige kansen blijven zien.

Het bedrijf evalueert verschillende opties met betrekking tot zijn resterende Homecare belangen in het Verenigd Koninkrijk, Ierland, Argentinië en Brazilië. Air Products zal deze bedrijfsactiviteiten blijven uitvoeren als onderdeel van haar portfolio. Het doel blijft daarbij om nieuwe zaken te winnen en blijvend kwalitatieve patiëntenzorg af te leveren. Meer in het algemeen wil Air Products Healthcare rendabele kansen blijven bieden aan ziekenhuizen en andere zorgverstrekkers met de aanlevering van gassen en gerelateerde diensten.

Over Air Products
Air Products (www.airproducts.com) levert stikstof, zuurstof en argon, procesgassen, zoals waterstof en koolmonoxide, specialiteitsgassen en performance chemicals voor de sectoren technologie, (petro)chemie, energie, medisch en industrieel. Air Products staat wereldwijd bekend om haar innovatieve cultuur, de operationele vakkundigheid en de verantwoordelijkheid voor veiligheid en milieu. De jaaromzet bedroeg in het boekjaar 2011 meer dan 10,1 miljard dollar. Bij Air Products werken wereldwijd ruim 18.900 medewerkers verdeeld over 40 landen.

NOOT: Dit bericht kan zogenaamde ‘toekomstgerichte verklaringen’ bevatten als bedoeld in de Amerikaanse Private Securities Litigation Reform Act uit 1995. Deze toekomstgerichte verklaringen zijn gebaseerd op de redelijke verwachtingen en veronderstellingen van het management op datum van dit bericht met betrekking tot belangrijke risicofactoren. De werkelijke prestaties en financiële resultaten kunnen materieel verschillen van de voorspellingen en schattingen die worden weergegeven in de toekomstgerichte verklaringen, omdat een of meerdere factoren mogelijks niet werden geanticipeerd door het management. Deze factoren bevatten onder meer de risicofactoren die zijn beschreven in het Document 10K van de onderneming voor het fiscale jaar dat op 30 september 2011 werd beëindigd.

Perscontact:
Hans Karperien
Tel.: +32 (0)2 627 06 00
Email: hans@insticom.be

Air Products plant, Homecare-Geschäft in Kontinentaleuropa an die Linde Group zu veräußern

Mon, 09 Jan 2012 00:00:00 -0500

Der US-amerikanische Industriegasehersteller Air Products hat sich mit der Linde Group auf den Verkauf des Homecare-Geschäfts in Kontinentaleuropa geeinigt. Bestandteil der Einigung ist der Verkauf des Homecare-Geschäfts in Belgien, Frankreich, Deutschland, Portugal und Spanien an Linde. Die Transaktionen unterliegen gesetzlichen Genehmigungen und Anforderungen an Mitarbeitergespräche.

Der Kaufpreis für das Homecare-Geschäft von Air Products in Kontinentaleuropa beträgt 590 Mio. Euro, je nach vereinbarten Bedingungen bei Geschäftsabschluss.

Die Einigung umfasst den Verkauf von Services für die patientenorientierte Sauerstoff-, Schlaf- und Infusionstherapie in Kontinentaleuropa. Der Geschäftsbereich versorgt in den fünf genannten Ländern einen Patientenbestand von ca. 260.000 Patienten und erzielte im Jahr 2011 einen Umsatz von rund 210 Mio. Euro.

John McGlade, Chairman, President und CEO von Air Products, zu den Hintergründen des Verkaufs: „Unser kontinentaleuropäisches Homecare-Team hat viele Jahre lang erfolgreich gewirtschaftet und uns damit Führungspositionen im Markt verschafft. Der Trend hat sich jedoch in jüngster Zeit weg von Flaschengasen und hin zu der Versorgung durch Konzentratoren sowie zu nicht Sauerstoff basierten Therapien entwickelt. Diese Entwicklungen passen nicht mehr zu unserem Kerngeschäft mit Gasen. Unsere Wachstumsstrategie liegt auf den Energie-, Umwelt- und aufstrebenden Märkten, in denen wir deutliche Entwicklungschancen sehen.“

„Deutschland ist ein wichtiger Markt für uns. So versorgen wir beispielsweise die Brennstoffzellen-U-Boote der deutschen Marine mit Wasserstoff. Strategisch wichtig ist zudem, dass sich in Deutschland auch unser Performance Material Polyurethane Technology Centre für Europa und den Nahen Osten befindet, in dem wir kürzlich ein Investment-Programm für den weiteren Ausbau unserer Test- und Support-Möglichkeiten abgeschlossen haben, “ erklärt Graham Rhodes, Regional Vice President Global Merchant Gases Strategy und Business Development bei Air Products.

Air Products prüft derzeit verschiedene Möglichkeiten hinsichtlich des verbliebenen Homecare-Geschäfts in Großbritannien, Irland, Argentinien und Brasilien. Das Unternhemen führt diese Geschäftsbereiche als Teil des Unternehmensportfolios fort, um zusätzliche Marktanteile zu gewinnen und eine qualitativ hochwertige Patientenversorgung zu gewährleisten. Der übergreifende Bereich „Healthcare“ bietet für Air Products mit Großabnehmern medizinischer Gase und den zugehörigen Services für Krankenhäuser und andere Pflegeanbieter weiterhin profitable Möglichkeiten.

Über Air Products
Air Products (Air Products and Chemicals, Inc.) bietet seinen Kunden in Industrie, Energiewirtschaft und Gesundheit ein weltweit einzigartiges Portfolio von Industrie-, Prozess- und Spezialgasen, Hochleistungsmaterialien sowie Anlagen und Dienstleistungen. Seit seiner Gründung im Jahr 1940 hat sich Air Products eine führende Stellung in bedeutenden Wachstumsmärkten wie der Halbleiterindustrie, der Wasserstofferzeugung, der Erdgasverflüssigung und des Gesundheitswesens sowie moderner Schicht- und Klebstoffe erarbeitet. Im Mittelpunkt der Unternehmenskultur stehen Innovation, effiziente Prozesse und ein umfassendes Sicherheits- und Umweltbewusstsein. Air Products erzielte im Geschäftsjahr 2011 einen Umsatz von mehr als 10.1 Milliarden US-Dollar und beschäftigte in mehr als 40 Ländern 18.900 Mitarbeiter. Weitere Informationen finden Sie unter www.airproducts.de.

Pressekontakt:
Alexander Hirsch
Script Corporate+Public Communication
Feuerbachstr. 26-32
60325 Frankfurt am Main
Tel.: +49 69 92020 - 875
Email: a.hirsch@script-com.de

Air Products Announces Plan to Divest Homecare Business in Continental Europe to The Linde Group

Mon, 09 Jan 2012 00:00:00 -0500

Air Products (NYSE:APD) today announced it has reached agreements for The Linde Group to purchase its Homecare business in Belgium, Germany, France, Portugal and Spain. The transactions are subject to regulatory approval and employee consultation requirements.

The total purchase price for Air Products’ Continental Europe Homecare business will be €590 MM, subject to terms agreed upon completion.

The agreements cover the sale of Air Products’ patient-based oxygen-therapy, sleep-therapy and infusion-therapy services in Continental Europe. This business serves a total patient base around 260,000 in all five countries and had revenue of approximately €210 MM last year.

Chairman, President and CEO John McGlade said, “Over many years, our Continental European Homecare team has run a successful business, helping us to build several leadership positions. With the more recent trends towards concentrators and non-oxygen therapies, we feel it is no longer a natural fit with our core gases business. Our growth strategy lies in the energy, environmental and emerging markets in which we continue to see significant opportunities.”

The company is assessing several options in regards to its remaining Homecare interests in the UK, Ireland, Argentina and Brazil. Air Products will continue to operate these businesses as part of its portfolio, competing to win new business and providing quality patient care. More broadly, Healthcare continues to offer profitable opportunities through the supply of merchant gases and related services to hospitals and other care providers.

Air Products serves customers in industrial, energy, technology and healthcare markets worldwide with a unique portfolio of atmospheric gases, process and specialty gases, performance materials, and equipment and services. Founded in 1940, Air Products has built leading positions in key growth markets such as semiconductor materials, refinery hydrogen, home healthcare services, natural gas liquefaction, and advanced coatings and adhesives. The company is recognized for its innovative culture, operational excellence and commitment to safety and the environment. In fiscal 2011, Air Products had revenues of $10.1 billion, operations in over 40 countries, and 18,900 employees around the globe. For more information, visit www.airproducts.com.

NOTE: This release may contain forward-looking statements within the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. These forward-looking statements are based on management’s reasonable expectations and assumptions as of the date of this release regarding important risk factors. Actual performance and financial results may differ materially from projections and estimates expressed in the forward-looking statements because of many factors not anticipated by management, including risk factors described in the Company’s Form 10K for its fiscal year ended September 30, 2011.

Air Products Announces North America Price Increase for Liquid and Bulk Helium Gases

Thu, 15 Dec 2011 00:00:00 -0500

Effective January 1, 2012, or as contracts permit, Air Products (NYSE: APD) will be implementing a price increase for liquid and bulk helium gases in North America. Specific adjustments are being communicated directly to customers.

The price increase is the result of several factors. The global helium market continues to experience severe shortages in the supply needed to meet the world’s growing demand. The industry-wide shortage has made it increasingly difficult to maintain Air Products’ global system for meeting customer requirements, and unfortunately this situation is expected to continue well into the future. Air Products has incurred increased costs to operate in this manner, as its worldwide helium team is managing this difficult situation on a daily basis in order to maintain uninterruptible supply to customers.

NOTE: This release may contain forward-looking statements within the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. These forward-looking statements are based on management’s reasonable expectations and assumptions as of the date of this release regarding important risk factors. Actual performance and financial results may differ materially from projections and estimates expressed in the forward-looking statements because of many factors not anticipated by management, including risk factors described in the Company’s Form 10K for its fiscal year ended September 30, 2011.

Air Products Healthcare souligne le lien entre diabète et apnée du sommeil

Mon, 14 Nov 2011 00:00:00 -0500

A l'occasion de la Journée Mondiale du Diabète1 et du prochain Congrès du Sommeil2, Air Products Healthcare met à disposition du grand public, via les professionnels de santé, un nouveau titre dans la collection des Carnets du Sommeil de l'INSV (Institut National du Sommeil et de la Vigilance) : « Sommeil & Diabète ». Ce livret de 16 pages explique dans un langage simple la pathologie, ses symptômes, ses liens avec le sommeil et les solutions existantes, le tout complété par des conseils pratiques pour améliorer la qualité de vie du patient. En supplément, un agenda du sommeil permet au lecteur de préparer sa première consultation avec un spécialiste. Ce carnet est accompagné d'une affiche « Troubles du Sommeil – Attention Diabète » pour sensibiliser les patients sur ce sujet.

En s'associant à la publication de ce N°8 des Carnets du Sommeil, Air Products Healthcare, Spécialiste dans la prise en charge des patients sous insulinothérapie par pompe et traités pour le syndrome d'apnée du sommeil, a pour objectif de mettre en avant le lien qui peut exister entre le diabète et l'altération de la qualité du sommeil. La filiale médicale du Groupe Air Products montre ainsi une fois de plus sa volonté à établir des relations fondées sur le dialogue et le partenariat avec les médecins et tous les professionnels de santé afin de mieux servir le patient et lui assurer une meilleure qualité de vie.

C'est avec ce même objectif qu'Air Products Healthcare a conçu en 2010 le Programme Adhérence APMedicalDirect®, un système innovant de suivi en ligne des patients pris en charge pour l'apnée du sommeil, l'oxygénothérapie et la ventilation, afin d' améliorer leur observance aux traitements ainsi que la qualité des soins. Aujourd'hui, plus de 350 000 personnes à travers l'Europe peuvent ainsi compter sur le service et les équipes pluridisciplinaires d'Air Products Healthcare qui met le patient au cœur de son métier.

La journée mondiale du Diabète
Organisée par la Fédération Internationale du Diabète (FID) et soutenue par l’OMS, c’est la plus importante campagne mondiale de sensibilisation au diabète. Lancée en 1991 en réponse à l’escalade de l’incidence du diabète dans le monde, elle rassemble tous les 14 novembre (jour anniversaire de Frederick Banting, premier à avoir développé la théorie à l’origine de la découverte de l’insuline en 1922) des millions de personnes dont les leaders d’opinion, les professionnels et prestataires de soins de santé, les médias, les malades et le grand public. Pour plus d’informations, rendez-vous sur www.journee-mondiale.com/42/14_novembre-diabete.htm.

Le Congrès du sommeil
Organisé par La Société Française de Recherche et Médecine du Sommeil et la Société de Pneumologie de Langue Française, le Congrès du Sommeil est un lieu d’échanges et de rencontres entre professionnels de la santé, chercheurs, décideurs publics, associations de patients, prestataires de soins à domicile, industriels et fournisseurs de matériels, qui rassemble chaque années plus de 2 000 participants. Le prochain Congrès du sommeil aura lieu du 24 au 26 novembre 2011 à Strasbourg. Air Products Healthcare y participera et vous donne rendez-vous sur le stand N°52 Pour plus d’informations, rendez-vous sur www.lecongresdusommeil.com.

A propos d’Air Products Healthcare
A l'écoute et au service du patient et des professionnels de santé, Air Products Healthcare – filiale médicale du groupe Air Products – fournit des services d'oxygénothérapie, pression positive continue, ventilation assistée, aérosolthérapie, aspiration trachéale, perfusion, nutrition et insulinothérapie par pompe à plus de 20 000 patients en France et 350 000 patients en Europe suivant ses traitements et soignés à domicile. Pour plus d’informations, rendez-vous sur www.airproducts.fr/homecare.

BIG Supports O2 Medical Grade to Help Patients in Flood Areas

Tue, 25 Oct 2011 00:00:00 -0400

Management of Bangkok Industrial Gas Co., Ltd. or BIG led by Senior Executive Director Chaiwat Niyomkarn (5th from right), recently teamed up to Ayudhya province to present 70 cylinders of oxygen medical grade to the Center of Flood Relief in Ayudhya to help patients get stuck there. The support will continue until the flood situation is eased.

This inundated is the worst of its kind as there are many victims waiting for helps. Stocks of oxygen are critical as the delivery was very difficult and some gas operations are closed. BIG has contacted the Public Health Ministry to offer the help.

The first delivery has departed to Ayudhya in the morning of 17 October 2011 together with dried foods, rice, drinking water, and other essential items have been donated from BIG employees.

For more information please contact:
Bangkok Industrial Gas Co., Ltd.
Ms. Jintana Prasertkarnchana
Tel. 0-2685-8566 / Fax. 0-2685-6790 /
Email : jintanak@bigth.com

Air Products Secures 25% Stake in Gases Businesses of Abdullah Hashim Group

Thu, 29 Sep 2011 00:00:00 -0400

Air Products (NYSE: APD) today announced it has agreed to acquire a 25 percent stake in the gases and equipment businesses of Abdullah Hashim Industrial Gases & Equipment Co. Ltd. (AHG), a company of the privately-owned Abdullah Hashim Group, based in The Kingdom of Saudi Arabia. The transaction is subject to regulatory approval and customary local closing conditions. Financial terms are not being disclosed.

AHG is the largest private industrial gases company in Saudi Arabia. It is comprised of three businesses, including industrial gases, equipment, and consumables and refrigerants. AHG has three main production locations in Dammam, Jeddah and Riyadh, plus distribution centers at key locations across The Kingdom. AHG also has a purchase agreement with National Industrial Gases Company (NIGC) at Jubail and Yanbu for liquid products.

“AHG is a long-established, respected and financially strong business, run by an experienced leadership team,” said Howard Castle-Smith, Air Products’ vice president and general manager, Tonnage Gases, Europe and Middle East. “Merchant gases growth in The Kingdom is high, and margins are strong, making it an attractive investment. It’s also a significant new platform from which to pursue tonnage gases opportunities in The Middle East.”

Air Products and AHG have a long-standing relationship and currently operate two joint ventures. One is an on-site facility supplying oxygen and nitrogen for Shadeed Iron & Steel’s production plant in the Sohar Industrial Port of Oman. The other plant supplies nitrogen and hydrogen to Emirates Float Glass in Abu Dhabi, the United Arab Emirates.

“We see Air Products as the ideal partner to expand our business across The Middle East,” said Khalid Hashim, AHG’s managing director. “Our relative strengths – AHG in the supply of merchant gases and Air Products in large scale tonnage plants – make us stronger together. Of course, Air Products is a leader in merchant gases in many other parts of the world, and I expect us to benefit from their capability in new technologies and product innovation that we will offer to our customers and prospects.”

Abdullah Hashim Group was founded in 1955 and is owned and operated by the Hashim family. The industrial gases business is a combination of liquid/bulk, pipeline products and a range of packaged gases products. AHG has a particularly strong presence in refining, primary metals markets, medical, food and aviation.

Air Products built the first ever air separation unit (ASU) in the Middle East in the 1950s and has 40 years of operating experience in the region. The company has been working with the petrochemical and refinery industries for decades, building, owning and operating ASUs and hydrogen production plants.

Air Products designed and built two of the world’s largest ASUs for Qatar Oryx GTL at its site in Ras Laffan. Air Products also owns an operating facility in the Jebel Ali Free Zone in the United Arab Emirates.

About Air Products
Air Products (NYSE:APD) serves customers in industrial, energy, technology and healthcare markets worldwide with a unique portfolio of atmospheric gases, process and specialty gases, performance materials, and equipment and services. Founded in 1940, Air Products has built leading positions in key growth markets such as semiconductor materials, refinery hydrogen, home healthcare services, natural gas liquefaction, and advanced coatings and adhesives. The company is recognized for its innovative culture, operational excellence and commitment to safety and the environment. In fiscal 2010, Air Products had revenues of $9 billion, operations in over 40 countries, and 18,300 employees around the globe. For more information, visit www.airproducts.com.

About the Abdullah Hashim Group
Abdullah Hashim Group, a family-owned Saudi company, has been in business for more than half a century. Turnover exceeds USD 450MM, and employs around 1,800 people. The group’s activities are in three main areas – the import and distribution of automotive vehicles, agricultural and industrial equipment, including the agency for Honda cars and motorcycles in Saudi Arabia; the distribution of welding equipment and related supplies; and the manufacture and distribution of a wide range of industrial and medical gases from three main production locations and seven distribution centers in the Kingdom of Saudi Arabia. Abdullah Hashim Gases offers project engineering infrastructure, including project design and installation, as well as extensive regional operation support and back-up liquid gases distribution. For more information, visit www.ahg.com.sa.

NOTE: This release may contain forward-looking statements within the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. These forward-looking statements are based on management’s reasonable expectations and assumptions as of the date of this release regarding important risk factors. Actual performance and financial results may differ materially from projections and estimates expressed in the forward-looking statements because of many factors not anticipated by management, including risk factors described in the Company’s Form 10K for its fiscal year ended September 30, 2010.

Air Products Announces North American Price Increase for Liquid and Bulk Industrial Gas Products

Thu, 15 Sep 2011 00:00:00 -0400

Effective, October 1, 2011, or as contracts permit, Air Products (NYSE: APD) will increase product pricing and monthly service charges for merchant customers in North America. The pricing adjustments include increases of:

– 5 to 10% for liquid oxygen, liquid nitrogen, liquid argon, liquid and bulk hydrogen; and;

– 3 to 5% for monthly service charges.

Some price adjustments may be outside of these ranges based on other specific situations.

The revised prices will offset higher operating costs and increased input costs. Air Products is taking aggressive actions internally to mitigate rising costs by reinvesting to improve efficiencies and maintain reliable supply.

NOTE: This release may contain forward-looking statements within the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. These forward-looking statements are based on management’s reasonable expectations and assumptions as of the date of this release regarding important risk factors. Actual performance and financial results may differ materially from projections and estimates expressed in the forward-looking statements because of many factors not anticipated by management, including risk factors described in the Company’s Form 10K for its fiscal year ended September 30, 2010.

Air Products Announces North America Price Increase for Liquid and Bulk Helium Gases

Mon, 15 Aug 2011 00:00:00 -0400

Effective September 1, 2011, or as contracts permit, Air Products (NYSE: APD) will be implementing a price increase of 15 percent for liquid and bulk helium gases in North America.

The pricing adjustment is the result of several factors including the continued strong demand over the past year for helium and significant reductions in supply. The helium market has been tight across the globe with product allocations implemented by the U.S. Bureau of Land Management and with many other global helium sources producing below capacity. Additionally, new helium sources located primarily outside of the U.S. are extremely expensive, wholesale prices for crude and processed liquid helium have increased, and costs have escalated for power and diesel.

Air Products’ worldwide helium team is managing this difficult situation on a daily basis so that it can continue to bring uninterruptible supply to customers. It is expected that demand will exceed supply for the next two to three years, thus creating ongoing shortages in the market.

NOTE: This release may contain forward-looking statements within the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. These forward-looking statements are based on management’s reasonable expectations and assumptions as of the date of this release regarding important risk factors. Actual performance and financial results may differ materially from projections and estimates expressed in the forward-looking statements because of many factors not anticipated by management, including risk factors described in the Company’s Form 10K for its fiscal year ended September 30, 2010.

Air Products Wins Royal Philips Electronics Supplier Award

Thu, 07 Jul 2011 00:00:00 -0400

Air Products (NYSE: APD), the world’s largest producer and supplier of liquid and gaseous helium, announced today it won the “Innovation for Growth 2010” award in Royal Philips Electronics Supplier Awards program. Air Products received the award for its work together with Philips to significantly reduce the amount of helium used at Philips’ Latham, New York manufacturing facility. The award was presented by Philips at a recent event held in Andover, Massachusetts.

“Customer service is essential in today’s globally competitive market and we are very proud to have our dedicated efforts in this essential area recognized by Philips,” said John Van Sloun, general manager, Worldwide Helium at Air Products. “We worked closely with Philips in restructuring a segment of its operations to reduce their overall usage of helium. The result benefits Philips from an operations and cost standpoint, and we retain a satisfied customer.” Van Sloun added that the reduced sales of helium to Philips will be used to grow Air Products' helium business beyond magnetic resonance imaging (MRI), and to supply the increasing demand for the product in several other product markets.

At Latham, Air Products and Philips are making further investments into the MRI manufacturing process by constructing new equipment that will enhance the helium recovery and recycle processes within the factory. The project is scheduled to be completed during the summer of 2012, and once operational the new equipment will significantly reduce the amount of helium purchased by Philips. Air Products had previously worked with Philips at its facility in Best, Holland to install a similar system.

In selecting the winner, Philips noted that its judges were convinced that Air Products deserved the Innovation Award. Philips added that in a tough market situation with strong upward helium price pressure, Air Products worked together with Philips to mitigate this price pressure by restructuring the Latham Factory operations and investing in new equipment, resulting in the significant reduction in helium consumption.

Philips uses liquid helium at Latham to cool down the magnets they manufacture for the MRI industry and to test them prior to final placement at medical imaging facilities. A substantial amount of helium is used in the manufacturing and testing of these MRI magnets, which must be cooled to -452 degrees Fahrenheit.

Air Products assists the global MRI industry with vital service by keeping the superconducting magnets at cryogenic temperatures to provide the highest quality medical imaging. An MRI system with a superconducting magnet consists of many wound coils of wire through which a current of electricity is passed to create a magnetic field. This requires a significant amount of energy and is achieved through superconductivity, or reducing the resistance in the wires to almost zero by continually bathing the wire coils in liquid helium.

Helium is used in many unique and valued applications beyond MRI including: lifting for high altitude scientific research balloons, blimps and party balloons; fiber optics and semi-conductor manufacturing; metallurgy; breathing atmospheres for deep diving or unique blood gas medical mixtures; analytical chemistry; pressurizing and purging pipes, vessels, and other critical equipment; leak detection; and other advanced applications.

Air Products (NYSE:APD) serves customers in industrial, energy, technology and healthcare markets worldwide with a unique portfolio of atmospheric gases, process and specialty gases, performance materials, and equipment and services. Founded in 1940, Air Products has built leading positions in key growth markets such as semiconductor materials, refinery hydrogen, home healthcare services, natural gas liquefaction, and advanced coatings and adhesives. The company is recognized for its innovative culture, operational excellence and commitment to safety and the environment. In fiscal 2010, Air Products had revenues of $9 billion, operations in over 40 countries, and 18,300 employees around the globe. For more information, visit www.airproducts.com.

NOTE: This release may contain forward-looking statements within the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. These forward-looking statements are based on management’s reasonable expectations and assumptions as of the date of this release regarding important risk factors. Actual performance and financial results may differ materially from projections and estimates expressed in the forward-looking statements because of many factors not anticipated by management, including risk factors described in the Company’s Form 10K for its fiscal year ended September 30, 2010.

Air Products Teams Up with Marie Curie in Data Protection Expertise Exchange

Tue, 19 Apr 2011 00:00:00 -0400

Industrial gas and chemicals manufacturer Air Products and end of life care charity Marie Curie Cancer Care have joined forces to share skills and expertise in the area of data privacy and protection.

The two organisations, which both handle personal data, identified an opportunity to share experience and knowledge about data privacy, based on parallels in their respective fields of work. Marie Curie Cancer Care provided care to more than 31,000 terminally ill patients at home or in its nine hospices last year, and Air Products' Healthcare division provides home oxygen to over 325,000 patients throughout Europe.

On 6 April 2010, the Government's Information Commissioner's Office (ICO) was handed extended powers to enhance the enforcement of the UK Data Protection Act. For many organisations these moves demonstrate the increasing importance in all sectors around handling personal and sensitive data.

The agreement between the two organisations saw Air Products share with Marie Curie its experience of developing and integrating a data protection programme which included lessons learned from both technical and change management perspectives. Marie Curie will use the expertise to inform the design of a new employee training and awareness programme to be launched this spring.

Shash Patel, Director of Information Risk Management and Privacy at Air Products explained: "It is more and more necessary to proactively manage the way in which data is handled; from risk assessing and monitoring "data assets', to employee change management programmes which foster a strong culture of individual responsibility. All of this requires focused resources and we recognise that lessons from Air Products' data protection journey are of real value to others with similar obstacles. Sharing this experience with Marie Curie Cancer Care means that we are not only helping a leading UK charity, but we are continuing to define standards in the area of data protection as a whole."

According to the Charities Aid Foundation's World Giving Index 2010, 29% of the UK's charitable giving occurs through volunteering activity. Shash added: "Philanthropy is an important corporate responsibility, however in some cases, sharing relevant skills and knowledge can be of greater long-term value. With Marie Curie Cancer Care we have seen firsthand that this kind of partnership works and as part of the data protection movement, together we're adopting a new kind of best practice that really makes a difference."

Trevor Lake, Company Secretary at Marie Curie Cancer Care commented: "Spending time with the Air Products Data Protection team has helped us to understand the challenges in creating a robust and effective data handling programme for the long-term and how to overcome these. Their contribution of expertise and tried-and-tested approaches has saved us both time and money. Privacy and confidentiality are priorities for Marie Curie Cancer Care and we'd like to thank Air Products for helping us continue to set the highest standards so that our patients, employees, volunteers and supporters know that their data is in safe hands."

About Air Products
Air Products (NYSE:APD) serves customers in industrial, energy, technology and healthcare markets worldwide with a unique portfolio of atmospheric gases, process and specialty gases, performance materials, and equipment and services. Founded in 1940, Air Products has built leading positions in key growth markets such as semiconductor materials, refinery hydrogen, home healthcare services, natural gas liquefaction, and advanced coatings and adhesives. The company is recognized for its innovative culture, operational excellence and commitment to safety and the environment. In fiscal 2010, Air Products had revenues of $9 billion, operations in over 40 countries, and 18,300 employees around the globe. For more information, visit www.airproducts.com.

About Marie Curie
Marie Curie Cancer Care is one of the UK's largest charities. Employing more than 2,700 nurses, doctors and other healthcare professionals, it provided care to more than 31,000 terminally ill patients in the community and in its nine hospices last year and is the largest provider of hospice beds outside the NHS.

Funding
Around 70 per cent of the charity's income comes from the generous support of thousands of individuals, membership organisations and businesses, with the balance of our funds coming from the NHS.

Marie Curie Nurses
The charity is best known for its network of Marie Curie Nurses working in the community to provide end of life care, totally free for patients in their own homes.

Research
The charity provides core funding for two centres for palliative care research, the Marie Curie Palliative Care Research Unit at University College London and the Marie Curie Palliative Care Institute Liverpool. It also supports palliative and end of life care research through its project grant funding streams, the Marie Curie Cancer Care Research Programme (administered by Cancer Research UK) and the Dimbleby Marie Curie Cancer Care Research Fund.

Supporting the choice to die at home
Research shows around 65 per cent of people would like to die at home if they had a terminal illness, with a sizeable minority opting for hospice care. However, more than 50 per cent of cancer deaths still occur in hospital, the place people say they would least like to be. Since 2004 Marie Curie Cancer Care has been campaigning for more patients to be able to make the choice to be cared for and die at home.

Air Products Lands Contract with Genesis for KeepCOLD® Cryogenic Services

Wed, 23 Mar 2011 00:00:00 -0400

Air Products (NYSE: APD) announced today the signing of a long-term contract with Genesis Medical Imaging, Inc., one of the United States’ largest independent MRI (magnetic resonance imaging) service providers based in Huntley, Illinois. Under the agreement, Air Products will supply its KeepCOLD® Cryogenic Services product offering for approximately 150 magnets currently installed by Genesis for MRI scans at medical service providers across the country.

“The contract with Genesis is the largest we have signed in the independent sector to date. We believe this market will present further opportunities and we will continue to grow that end of the business with our established offerings,” said Shawn Smith, product manager - North America Helium at Air Products. “In this growing market we are able to use the wealth of experience we have gained working closely with original equipment manufacturers (OEMs), be able to continue to provide that experience to our OEM customers, and now transition that knowledge to our work with Genesis and other independents as well.”

“Air Products’ enviable quality and OEM experience make a superb fit with Genesis’ unique position to provide customers the excellence and security of an OEM relationship with the pricing and responsiveness of independent service,” said Robert Dakessian, Genesis president and CEO. “Air Products’ reliability can mean more uptime, another step in Genesis’ promise of continuous improvement in quality and value from a service partner you can trust.”

Smith said he believed Air Products’ 20 years of MRI servicing experience, as well as its product offerings’ flexibility to meet the specific needs of the customer, were essential to gaining the Genesis contract. “We have been and are the leading third-party service provider in this industry,” Smith said. “This contract enables Air Products to continue to expand our customer base in this market and to increase our present work with the independent MRI segment of the medical services industry.”

Air Products, the largest international supplier of helium, assists the MRI industry with vital service by keeping the superconducting magnets at cryogenic temperatures to provide the highest quality medical imaging. An MRI system with a superconducting magnet consists of many wound coils of wire through which a current of electricity is passed to create a magnetic field. This requires a significant amount of energy and is achieved through superconductivity, or reducing the resistance in the wires to almost zero by continually bathing the wire coils in liquid helium at approximately -452 degrees Fahrenheit.

There are more than 12,000 MRI magnets using Air Products' helium and cryogenic gases to keep them cold and superconducting for the medical services industry. This current total includes more than half of the existing magnets in U.S. and internationally. At more than 7,500 KeepCOLD sites Air Products performs 13,000 helium fills annually, which has led to long-standing relationships with the leading MRI original equipment manufacturers. For more information on Air Products’ KeepCOLD product services go to www.airproducts.com/helium/applications/mri.htm.

About Air Products

Air Products (NYSE:APD) serves customers in industrial, energy, technology and healthcare markets worldwide with a unique portfolio of atmospheric gases, process and specialty gases, performance materials, and equipment and services. Founded in 1940, Air Products has built leading positions in key growth markets such as semiconductor materials, refinery hydrogen, home healthcare services, natural gas liquefaction, and advanced coatings and adhesives. The company is recognized for its innovative culture, operational excellence and commitment to safety and the environment. In fiscal 2010, Air Products had revenues of $9 billion, operations in over 40 countries, and 18,300 employees around the globe. For more information, visit www.airproducts.com.

About Genesis

Genesis Medical Imaging is the largest independent service organization to offer a total solution for CT and MRI needs, including nationwide service contracts, mobiles, refurbished CT & MRI equipment, cryorefrigeration and magnet services. Visit www.genesismedicalimaging.com.

Air Products to Site New ASU and Modernize Middletown, Ohio Operations

Thu, 17 Feb 2011 00:00:00 -0500

Air Products (NYSE: APD) today announced it will build, own, and operate a new air separation unit (ASU), a new hydrogen production facility and will make additional investment in an existing ASU and liquefier which has been producing industrial gases in Middletown, Ohio. The new facilities, planned to be on-stream in the fourth quarter of 2012, will provide additional capacity to meet customer demand for industrial gases and merchant liquid products in the region.

“Air Products has supplied customers in Middletown and the surrounding region with on-site and merchant gases since the 1960s. This new investment shows commitment to our customers in the Midwest market, it will expand our capability to serve the area, and it provides significant modernization of our operations there,” said Wilbur Mok, vice president–Tonnage Gases North America for Air Products. Mok noted that the new facilities will replace some smaller existing operations at this location to meet the increased demand for both on-site and merchant industrial gas products.

The new ASU will have production capacity of over 700 tons per day of combined pipeline and merchant oxygen output, and total argon capacity for the site will increase. Air Products will also generate hydrogen at Middletown to meet customer requirements with its PRISM® Hydrogen Generator steam methane reformer (SMR) producing over one million cubic feet per day of hydrogen. Air Products’ on-site hydrogen product offerings were enhanced by the 2008 acquisition of this novel and patented SMR technology with flexibility to meet the varied hydrogen capacity requirements of a customer.

Air Products (NYSE:APD) serves customers in industrial, energy, technology and healthcare markets worldwide with a unique portfolio of atmospheric gases, process and specialty gases, performance materials, and equipment and services. Founded in 1940, Air Products has built leading positions in key growth markets such as semiconductor materials, refinery hydrogen, home healthcare services, natural gas liquefaction, and advanced coatings and adhesives. The company is recognized for its innovative culture, operational excellence and commitment to safety and the environment. In fiscal 2010, Air Products had revenues of $9 billion, operations in over 40 countries, and 18,300 employees around the globe. For more information, visit www.airproducts.com.

NOTE: This release may contain forward-looking statements within the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. These forward-looking statements are based on management’s reasonable expectations and assumptions as of the date of this release regarding important risk factors. Actual performance and financial results may differ materially from projections and estimates expressed in the forward-looking statements because of many factors not anticipated by management, including risk factors described in the Company’s Form 10K for its fiscal year ended September 30, 2010.

"¿Vivir sin Fumar? Podemos Conseguirlo: Nueva Guia de Educacion Sanitaria de Carburos Medica

Tue, 08 Feb 2011 00:00:00 -0500

Más de trece millones de personas fuman en nuestro país, y según los datos disponibles, son muchas las que desean dejarlo aunque reconocen que es proceso es complicado. Con el objetivo de ayudar a ganar la batalla contra el tabaco y bajo el lema "Al lado de los pacientes", Carburos Médica ha editado la guía "¿Vivir sin fumar? Podemos conseguirlo", una guía de educación sanitaria que ofrece una serie de consejos y recomendaciones para dejar el hábito tabáquico y, por tanto, mejorar así el estado físico y la calidad de vida.

Ser realista, estar motivado y saber solicitar ayuda sanitaria son las principales herramientas para dejar de fumar. La guía editada por Carburos Médica propone pautas a seguir antes de decidir el día concreto de dejar el hábito, durante ese mismo día, así como en los posteriores. Así antes de la fecha señalada, es importante elaborar una lista de motivos por los que hemos decidido dejar de fumar, avisar a las personas del entorno y, por supuesto, consultar con los profesionales sanitarios la decisión tomada para que nos orienten.

Una vez que se ha fijado el día es fundamental deshacerse de todos los ceniceros, mecheros y demás utensilios. Según este manual, también es clave no desanimarse si no se consigue dejarlo a la primera, así como seguir un horario de comidas regular, no consumir alcohol, cafés y aperitivos que suelen ir asociados al tabaco, beber líquido abundante y evitar ambientes con humo y personas fumadoras.

Según explica la guía, para mantenerse sin fumar resulta de gran ayuda rodearse de personas que quieran dejar el tabaco con las que poder compartir la experiencia, así como realizar ejercicios de relajación y respiración profunda, ejercicio físico moderado, y sobre todo, comenzar a realizar actividades distintas que rompan la rutina diaria y nos mantengan distraídos.

Dolencias de los Fumadores

Más de 40 componentes del humo del tabaco son cancerígenos. El tabaquismo es la causa reconocida de varios tipos de cáncer y su consumo está claramente asociado con el desarrollo de numerosas enfermedades, no solamente relacionadas con el aparato respiratorio como el cáncer de pulmón, la EPOC, las infecciones respiratorias, etc., sino que también es causa de patologías que afectan a otros órganos como pueden ser las enfermedades cardiovasculares (infarto agudo de miocardio, trombosis y hemorragias cerebrales), enfermedades digestivas (úlcera péptica), enfermedades ginecológicas (impotencia, esterilidad), enfermedades psiquiátricas, enfermedades periodontales, etc.

Para animar a los fumadores a dejar el hábito esta guía incluye los beneficios del abandono del tabaco a corto y largo plazo. Si veinte minutos después del último cigarrillo mejoran la circulación periférica, la presión arterial y la frecuencia cardíaca, 24 horas más tarde el riesgo de muerte súbita disminuye y se recuperan los sentidos del olfato y del gusto. Durante los tres primeros meses de deshabituación disminuye la tos, aumenta la capacidad física y respiratoria y mejora la circulación. Tras un año sin fumar, el riesgo de infarto se reduce al 50%, mientras que a partir de los cinco años la tasa media de muerte por cáncer de pulmón se reduce de 137 a 72 por cada 100.000 personas.

Sobre Carburos Médica-Grupo Air Products
Compañía pionera en la innovación de mejoras para los pacientes con enfermedades respiratorias, Carburos Médica cuenta con más de 65 años de experiencia en el sector sanitario y es líder nacional en gases medicinales y en servicios sanitarios a domicilio. Su mentalidad fundamentalmente sanitaria le hace única dentro del sector gasista de nuestro país, explorando y desarrollando nuevos caminos que, en colaboración con diferentes socios, beneficien la salud y calidad de vida de la sociedad.

Air Products presta servicio a clientes en los mercados tecnológico, energético, sanitario e industrial de todo el mundo, ofreciendo una oferta global de productos, servicios y soluciones en gases atmosféricos, especiales y de proceso, así como materiales de alto rendimiento e intermedios químicos.

Fundada en 1940, Air Products es líder en mercados clave como semiconductores, refinería de hidrógeno, servicios de asistencia sanitaria, licuefacción de gas natural y recubrimientos avanzados y adhesivos. La compañía es reconocida por su cultura innovadora, su excelencia operacional y su compromiso con la seguridad y el medioambiente y está incluida en el Dow Jones Sustainability y el FTSE4Good Indices. La compañía opera en más de 40 países y cuenta con más de 18.300 empleados en todo el mundo, con unos ingresos en el año fiscal de 2010 de 9 billones de dólares. Más información en www.airproducts.com.

Air Products’ India Joint Venture Investing in Three New Merchant Gases Plants; Building a Fourth Plant for Long-Term Supply to Saint Gobain Glass

Tue, 14 Dec 2010 00:00:00 -0500

Air Products (NYSE: APD)today announced that INOX Air Products Ltd., its joint venture (JV) in India, will construct three air separation units (ASU) and liquefiers for the merchant market and also will build a fourth plant for long-term industrial gas supply to Saint Gobain Glass India. The four facilities are scheduled to come on stream during 2012.

“We are the market leader in merchant industrial gases in India, and these new plants are part of our strategy to continue to provide efficient and reliable product to support the strong growth in India. The anticipated manufacturing growth is more than seven percent annually over the next five years, and the demand for industrial gases has been steadily increasing,” said Pavan K. Jain, managing director of INOX Air Products. “The investments strengthen INOX Air Products’ existing substantial presence throughout India and reinforce our supply positions which we have achieved through our strong customer focus.”

INOX Air Products will build the ASU and liquefier merchant plants to produce liquid oxygen, liquid nitrogen, and liquid argon in the states of Himachal Pradesh, Gujarat and Puducherry. All three locations have a strong manufacturing base, and these cost-effective facilities are strategically located close to the principal markets that they serve.

INOX Air Products will also build an ASU and liquefier for the merchant market and signed a long-term supply contract for nitrogen and hydrogen with Saint Gobain Glass India (SGGI). The production plants, to be located at SGGI’s facility in the state of Rajasthan, will supply nitrogen from the ASU by pipeline and hydrogen from a steam methane reformer (SMR) plant designed to meet the specific requirements of the customer. The SMR is a product offering from Air Products’ PRISM® gas generation portfolio.

“A customer-focused approach was essential in gaining our business. Reliable supply is very important to our project, and we believe INOX Air Products’ industrial gas expertise will deliver on our industrial gas needs,” said Mr. S.N. Eisenhower, director–Operations at Saint Gobain Glass India.

In adding these four new facilities, INOX Air Products’ market presence in India continues to grow. Earlier this year, the company announced a long-term contract with POSCO Maharashtra Steel Private Limited (PMSPL) to supply on-site nitrogen and hydrogen gases to its new facility in Vile Bhagad, Maharashtra, in western India. PMSPL is a subsidiary of POSCO, the world’s fourth largest steel producer by output. The nitrogen plant and the SMR are both product offerings from Air Products’ PRISM® gas generation portfolio. The plants are expected to come on stream in late 2011.

Air Products’ PRISM line of gas generation systems supply nitrogen, oxygen and hydrogen to more than 1,500 customers in over 30 countries worldwide. Air Products’ on-site hydrogen SMR offerings were enhanced by a technology acquisition in 2008 and offer flows across a wide range of requirements with highly efficient use of natural gas. Global markets currently served by Air Products entire PRISM line of gas generation systems include glass, steel, electronics and semiconductors, non-ferrous metals, metals processing, chemicals, food processing and packaging, and energy production and processing.

About Air Products

About INOX Air Products Ltd.

INOX Air Products Limited is a joint venture company in which the Jain family (former owners of the Industrial Oxygen Company) and Air Products hold an equal stake. Headquartered in Mumbai, INOX Air Products is one of the largest manufacturers of industrial gases in India with 36 plants spread throughout the country and a workforce of approximately 1,200. INOX Air Products Ltd. manufactures and supplies industrial gases including oxygen, nitrogen, helium, argon, carbon dioxide, hydrogen, and specialty gas mixtures throughout India. More information can be found at www.inoxairproducts.com.

NOTE: This release may contain forward-looking statements within the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. These forward-looking statements are based on management’s reasonable expectations and assumptions as of the date of this release regarding important risk factors. Actual performance and financial results may differ materially from projections and estimates expressed in the forward-looking statements because of many factors not anticipated by management, including risk factors described in the Company’s Form 10K for its fiscal year ended September 30, 2010.

LA OXIGENOTERAPIA MÓVIL PERMITE A LOS PACIENTES CRÓNICOS UNA VIDA CON CALIDA

Sun, 24 Oct 2010 00:00:00 -0400

Una veintena de pacientes, sus acompañantes y personal médico se han dado cita para participar en una Jornada de convivencia de pacientes con oxigenoterapia móvil, que ha consistido en una excursión en barco a la isla de Tabarca. De este modo, algunos de los afectados que habitualmente no se animan a realizar actividades fuera de sus domicilios debido a sus limitaciones físicas, han podido hacerlo ahora acompañados de personal médico. Esa posibilidad real de salir y tener una vida activa es preciso visibilizarla, tal como destacaba durante el recorrido el doctor Joan Gil Carbonell presidente de la Sociedad Valenciana de Neumología. “Y es que en la mayoría de los casos, sí que es posible abandonar el domicilio y realizar actividades, tanto de carácter laboral como lúdico que proporcionan bienestar y placer. Además -explicaba- iniciativas como ésta son un estímulo para ellos, que pueden compartir una jornada con personas en su misma situación, pero también para otros, que aunque no hayan participado ven cómo salir de casa es posible, a pesar de la terapia con oxígeno, gracias a los sistemas de ambulación de fácil manejo que existen”.Los participantes han sido, en su mayoría, afectados de Enfermedad Pulmonar Obstructiva Crónica (EPOC). Se estima que en nuestro país, el 9 por ciento de la población entre 40 y 60 años padece esta patología, cifra que aumenta hasta un 20 por ciento cuando se trata de pacientes que superan esas edades. Aunque muchos de ellos consiguen controlar la evolución de la enfermedad gracias a un diagnóstico y tratamiento adecuados, otros evolucionan de tal manera que la enfermedad deriva en una insuficiencia respiratoria u otras complicaciones. Cuando los niveles de oxígeno en la sangre descienden por debajo de 60 mmHg estaría indicada la oxigenoterapia crónica domiciliaria. Se estima que la prevalencia de la oxigenoterapia en España es de 115 por 100.000 habitantes, lo que implica que 60.000 pacientes con EPOC reciben tratamiento con oxigenoterapia.

En estos casos, el paciente debe recibir un suministro de oxígeno durante un tiempo mínimo estimado en 16 horas al día para que la terapia sea efectiva. En este punto, la oxigenoterapia móvil supone una importante mejora en la calidad de vida de los pacientes, ya que les permiten salir de su casa y aumentar su movilidad, manteniendo siempre una buena oxigenación. El encuentro, que tiene como objetivo mostrar tanto a los pacientes como al resto de la población que es posible hacer compatible un tratamiento con oxígeno y los hospitales de la provincia de Alicante. El director territorial de la Conselleria de Sanitat de la Generalitat Valenciana, José Ángel Sánchez-Navajas, que también participó en la excursión, expresó su apoyo absoluto a la iniciativa de Carburos Médica de organizar este tipo de eventos, “porque realmente compartir experiencias entre los pacientes y los médicos en un lugar diferente a la consulte es muy enriquecedor y, para los enfermos y sus familiares, muy satisfactorio”. Asimismo, manifestó el propósito de la Consellería de apoyar todas las iniciativas de estas características, independientemente de que se lleven a cabo desde el ámbito público o privado.

Oxigenoterapia móvil

La oxigenoterapia móvil, suministrada tanto mediante contenedor de oxígeno líquido portátil como a través de un concentrador portátil, aporta a los pacientes grandes beneficios ya que la movilidad es algo muy importante para cuando se precisa estar conectado a una fuente de oxígeno durante más de 16 horas al día para poder respirar. La elección de un tipo u otro de oxigenoterapia depende, fundamentalmente, del tipo de vida activa que el paciente es capaz de realizar. La oxigenoterapia móvil permite al paciente desplazarse con oxígeno fuera de su domicilio y la movilidad obtenida puede ser de varias horas o total dependiendo de la fuente de suministro.
En el caso del concentrador portátil, su tecnología le hace asemejarse al funcionamiento de un teléfono móvil ya que se recarga fácilmente en una fuente eléctrica y, además, dispone de baterías externas recargables. Aunque sus ventajas en cuanto a la mejora de la calidad de vida y de la libertad son claras, aún hay muchos pacientes que desconocen esta opción o piensan que “no está hecha para ellos”. Sin embargo, cualquier paciente que necesite oxígeno y que lleve una vida activa es susceptible de utilizar este tipo de tratamiento.

¿Qué es la EPOC?

La mayoría de los pacientes que precisan oxigenoterapia están diagnosticados de Enfermedad Pulmonar Obstructiva Crónica (EPOC), una afección pulmonar que se caracteriza fundamentalmente por la disminución de los flujos ventilatorios, dando así lugar a una obstrucción bronquial que, a la larga, conduce a la aparición de unos síntomas, entre los que el fundamental es la falta de aire o disnea. Si la enfermedad avanza a unos niveles en los que el aparato respiratorio es incapaz de mantener una adecuada cantidad de oxígeno en la sangre, será preciso el uso de oxigenoterapia.
El paciente con EPOC que recibe oxigenoterapia suele ser varón, con una larga historia de fumador y con unos 55 ó 60 años de edad. Cuando a estos aspectos se añaden otros problemas o patologías asociadas, como obesidad o alguna cardiopatía, entonces, puede adelantarse la edad de indicación de la terapia.

La primera medida terapéutica en todos los pacientes es el abandono del hábito tabáquico, responsable de la gran mayoría de los casos de EPOC. Además, antes de comenzar con la oxigenoterapia, está indicada la rehabilitación respiratoria para mejorar la condición ventilatoria y el uso correcto de broncodilatadores y corticoides inhalados. Sólo cuando estas medidas no son suficientes para mantener una adecuada oxigenación de la sangre, ha de plantearse dar un paso más y comenzar con el tratamiento con oxígeno crónico domiciliario.

Sobre Carburos Médica-Grupo Air Products
Compañía pionera en la innovación de mejoras para los pacientes con enfermedades respiratorias, Carburos Médica cuenta con más de 65 años de experiencia en el sector sanitario y es líder nacional en gases medicinales y en servicios sanitarios a domicilio. Su mentalidad fundamentalmente sanitaria le hace única dentro del sector gasista de nuestro país, explorando y desarrollando nuevos caminos que, en colaboración con diferentes socios, beneficien la salud y calidad de vida de la sociedad.

Air Products presta servicio a clientes en los mercados tecnológico, energético, sanitario e industrial de todo el mundo, ofreciendo una oferta global de productos, servicios y soluciones en gases atmosféricos, especiales y de proceso, así como materiales de alto rendimiento e intermedios químicos.

Fundada en 1940, Air Products es líder en mercados clave como semiconductores, refinería de hidrógeno, servicios de asistencia sanitaria, licuefacción de gas natural y recubrimientos avanzados y adhesivos. La compañía es reconocida por su cultura innovadora, su excelencia operacional y su compromiso con la seguridad y el medioambiente y está incluida en el Dow Jones Sustainability y el FTSE4Good Indices. La compañía opera en más de 40 países y cuenta con más de 18.900 empleados en todo el mundo, con unos ingresos en el año fiscal de 2009 de 8,3 billones de dólares. Más información en www.airproducts.com.

Selon une étude, les systèmes de gestion des patients peuvent contribuer à augmenter le taux d’adhésion aux thérapies respiratoires

Sun, 19 Sep 2010 00:00:00 -0400

Les tout derniers systèmes de gestion des patients sont capables de faire progresser les taux d’adhésion à leur traitement des patients bénéficiant de thérapies respiratoires à domicile, si l’on en croit l’étude menée par Air Products.

Fournisseur de services de soins spécialisés à domicile, en charge de plus de 325 000 patients en Europe, Air Products a mené une étude détaillée en France auprès d’un groupe échantillon de 1200 d’entre eux. L’objectif ? Evaluer l’impact de son système de gestion des patients sur l’adhésion à des thérapies respiratoires longue durée. Pour les patients souffrant d’OSAHS (Apnée-Hypopnée Obstructive du Sommeil), l’étude a montré une amélioration significative de leur adhésion à une thérapie de ventilation à pression positive continue (CPAP). La non-adhésion (prise en compte en dessous de moins de 3 heures par nuit de thérapie CPAP) a en effet baissé, passant d’un taux de 18,9% à 12,8% durant les 6 premiers mois de la mise en place du système. Pour 74% des patients identifiés comme présentant un risque élevé d’abandon de la thérapie, celui-ci a même été évité.

Dr Bibi Senor, Directeur Marketing pour le Médical chez Air Products Healthcare, a declare :
« Une piètre adhésion à la thérapie est un problème de longue date parmi les patients suivis sur le long terme et il existe maintenant une solution qui peut contribuer à y remédier. Notre étude a démontré que notre système innovant de gestion en ligne des patients peut aider à améliorer les soins en permettant aux cliniciens de repérer les facteurs de risque pour l’adhésion et donc d’intervenir précocement. Le système est par ailleurs simple à utiliser et peut contribuer à réduire le temps passé à gérer le patient. »

Les résultats de cette étude* sont dévoilés au moment où Air Products lance à l’échelle européenne son système innovant de gestion des patients, le Programme Adhérence APMedicalDirect®. Ce dernier fournit aux cliniciens une information actualisée sur l’historique thérapeutique de leurs patients et sur leur utilisation des services de soins à domicile, leurs permettant ainsi de repérer les changements ou les interruptions dans les thérapies prescrites et donc d’intervenir quand cela est nécessaire.

En sus d’une large gamme de services de soins à domicile, Air Products fournit aux hôpitaux de plus de 30 pays du monde entier, des gaz, des équipements et des conseils. Le Groupe est également le 1er fournisseur mondial d’hélium, gaz utilisé dans les systèmes d’imagerie à résonance magnétique (IRM).

Pour plus d’informations sur le Programme Adhérence APMedicalDirect®, rendez-vous sur www.airproducts.fr/APDAM.

A propos d’Air Products :
Air Products sert des clients dans l’industrie, l’énergie, la technologie et la santé à travers le monde entier grâce à un portefeuille unique de gaz de l’air, gaz process et gaz spéciaux, de matériaux de performance, d’équipements et de services. Fondé en 1940, Air Products a su prendre une place prépondérante sur des marchés clés comme les matériaux semi-conducteurs, l’hydrogène de raffinerie, les services de soins médicaux à domicile, la liquéfaction du gaz naturel, le coating et les adhésifs haute technologie. Le Groupe est reconnu pour sa culture de l’innovation, son excellence opérationnelle et son souci permanent de la sécurité et de l’environnement. Air Products a réalisé en 2009 un CA mondial de plus de 8, 3 milliards de dollars, est présent dans plus de 40 pays et emploie 18 900 employés à travers le globe. Pour plus d’informations, rendez-vous sur www.airproducts.com.

Air Products lance un système innovant de gestion des patients pour améliorer leur suivi thérapeutique

Mon, 13 Sep 2010 00:00:00 -0400

Air Products, acteur majeur dans le domaine des soins spécialisés à domicile, a conçu un innovant système en ligne de suivi des patients qui peut contribuer à améliorer leur adhésion à des thérapies respiratoires longue durée ainsi que la qualité des soins.

Ce système de gestion – le Programme Adhérence APMedicalDirect®– qui fonctionne en France depuis janvier dernier, va être lancé à l’échelle européenne à l’occasion des Congrès de l’ERS à Lisbonne (du 14 au 18 septembre prochain1) et de Barcelone (du 18 au 22 septembre 20102).

Mis au point par Air Products, le Programme Adhérence APMedicalDirect® offre une solution pratique aux praticiens qui veulent apporter une valeur ajoutée à la gestion de leurs patients en les dotant d’un système d’information moderne sur l’historique thérapeutique du traitement et des interventions. Il permet ainsi d’identifier toute évolution et facteurs de risques en matière d’adhérence et donc d’entreprendre des actions préventives suffisamment tôt.

Dans le cadre de ses services de soins à domicile spécialisés, Air Products founit des gaz médicaux et des équipements à plus de 325 000 patients à travers l’Europe. Ce système de gestion a été lancé avec succès pour les patients sous PPC (Ventilation en pression positive continue) en France début 2010. La totalité des patients du reste de l’Europe sera prise en charge par ce programme de soins dans les 12 prochains mois.

Dr Bibi Senor, Directeur Marketing pour le Médical chez Air Products Healthcare a déclaré :

« Ce système de suivi représente un important progrès dans le domaine des soins à domicile et une implantation effective des services de santé via internet. Aujourd’hui, Air Products offre aux praticiens une information précise et actualisée en temps réel sur le traitement en cours et le suivi des patients. Axé sur l’optimisation des soins, le Programme Adhérence APMedicalDirect® permet une coordination fondamentale des protocoles de soins et l’historique des interventions pour de meilleurs bénéfices . »

En complément d’une large gamme de services de soins à domicile, Air Products fournit aux hôpitaux de plus de 30 pays du monde entier des gaz, des équipements et des conseils. Le Groupe est également le 1er fournisseur mondial d’hélium, un gaz utilisé dans les systèmes d’imagerie à résonance magnétique (IRM).

Pour plus d’informations sur le Programme Adhérence APMedicalDirect®, rendez-vous sur www.airproducts.fr/APDAM.

1 Stand 209
2 Stand F104

A propos d’Air Products :
Air Products sert des clients dans l’industrie, l’énergie, la technologie et la santé à travers le monde entier grâce à un portefeuille unique de gaz de l’air, gaz process et gaz spéciaux, de matériaux de performance, d’équipements et de services. Fondé en 1940, Air Products a su prendre une place prépondérante sur des marchés clés comme les matériaux semi-conducteurs, l’hydrogène de raffinerie, les services de soins médicaux à domicile, la liquéfaction du gaz naturel, le coating et les adhésifs haute technologie. Le Groupe est reconnu pour sa culture de l’innovation, son excellence opérationnelle et son souci permanent de la sécurité et de l’environnement. Air Products a réalisé en 2009 un CA mondial de plus de 8, 3 milliards de dollars, est présent dans plus de 40 pays et emploie 18 900 employés à travers le globe. Pour plus d’informations, rendez-vous sur www.airproducts.com.

UN CUMPLIMIENTO ADECUADO DE LA TERAPIA CON OXÍGENO REDUCE INGRESOS HOSPITALARIOS Y CONSULTAS EN ATENCIÓN PRIMARIA

Mon, 19 Apr 2010 00:00:00 -0400

El cumplimiento de la terapia con oxígeno en las horas prescritas y con el flujo adecuado mejora la calidad de vida de los pacientes y reduce las consultas en Atención Primaria y los ingresos hospitalarios de los pacientes sometidos a este tratamiento. Ésta es la justificación sobre la cual se desarrolló VisionOx, un dispositivo de Carburos Médica, que mejora el control de esta terapia y que ya está disponible en los servicios de Neumología de los Hospitales Universitarios General de Alicante y Sant Joan de Alicante, como centros pioneros en la Comunidad Valenciana en la implantación de un nuevo equipo de referencia para monitorizar el cumplimiento terapéutico de la oxigenoterapia domiciliaria.

Este equipo -denominado Visionox®- permite a los neumólogos el control del cumplimiento terapéutico de los pacientes con oxigenoterapia de forma real y fiable. “El sistema realiza un seguimiento de la adherencia del paciente registrando el patrón de uso del oxígeno, las horas en las que está recibiendo la terapia y el valor del flujo medio administrado, de esta manera podemos valorar aquellos pacientes que están cumpliendo de forma óptima el tratamiento y detectar aquellos que no lo siguen de forma correcta”, ha destacado el jefe del servicio de Neumología de Sant Joan, Eusebi Chiner.

Estos datos quedan registrados en la plataforma informática APMedicalDirect®, la cual realiza informes diarios, mensuales, etc., sobre los hábitos del paciente, permitiendo a los profesionales evaluar el correcto cumplimiento de la oxigenoterapia y su relación con la mejoría o no del paciente. De esta forma, el sistema ofrece a los profesionales datos estadísticos sobre el universo de pacientes monitorizados.

Asimismo, se trata de una herramienta con un gran valor educativo para los enfermos respiratorios, ya que permite al personal sanitario (neumología, atención primaria, enfermería) informarles sobre los errores que cometen en la aplicación del tratamiento, dentro de los programas específicos de educación que requieren este tipo de pacientes.

Según afirma el Dr. Luís Hernández, médico del Servicio de Neumología del Hospital General Universitario de Alicante, “este servicio ha estado siempre muy preocupado por el correcto cumplimiento de la oxigenoterapia domiciliaria”. Tanto es así que, el Prof. S. Romero del Hospital General de Alicante realizó un estudio, en el año 1992, donde se mostraba un cumplimiento incorrecto en el número de horas de la oxigenoterapia domiciliaria.

“Gracias a este sistema”, ha apuntado Chiner, “también podrían evitarse ingresos hospitalarios de aquellos pacientes con enfermedad pulmonar obstructiva crónica (EPOC) que no realizan un control adecuado de la terapia con oxígeno, al detectarlo de manera precoz. La EPOC origina diez millones de consultas al año en Atención Primaria y unos 93.000 ingresos hospitalarios; parte de estas estancias podrían verse reducidas con un correcto cumplimiento del tratamiento”.

En las áreas dependientes del Hospital Sant Joan y General de Alicante existen más de 1500 pacientes en tratamiento con oxigenoterapia, de los cuales alrededor de 350 siguen sistemas móviles para permitir la deambulación, salir a la calle y efectuar una vida lo más autónoma posible. En estos momentos, un total de 40 pacientes entre ambos departamentos están participando en el programa piloto, aunque el objetivo planteado por los centros es que, progresivamente, la gran mayoría de estos pacientes puedan beneficiarse del equipo del control terapéutico de oxigenoterapia.

Beneficios de la oxigenoterapia

Cuando se produce un deterioro pulmonar por distintos motivos, uno de los principales es el tabaquismo, se produce un deterioro general del organismo (manifestado en debilidad y fatiga), así como la llamada “insuficiencia respiratoria”. Además de la medicación que pueda suministrarse, junto al cese del hábito tabáquico, puede ser necesario el suministro de oxígeno para compensar este proceso. Así, la oxigenoterapia ha demostrado mejorar la supervivencia, la calidad de vida de los pacientes y restaurar las actividades de la vida diaria.
Por lo que respecta a las fuentes de suministro de oxígeno, hasta hace unos años, los pacientes sólo disponían de bombonas que lo obligaban a permanecer en su domicilio, ya que el tiempo total de tratamiento no debe ser inferior a 15 horas diarias.

Los sistemas han ido evolucionando, mejorando la comodidad, por una parte, y por otra, permitiendo la movilidad. Así, surgieron los concentradores eléctricos, que suministran oxígeno enchufados a la corriente eléctrica, por lo que ya permitieron una movilidad dentro de casa o fuera de ella, siempre que hubiera una fuente de electricidad. Posteriormente, surgió el llamado oxígeno líquido que, a partir de una fuente nodriza fija, permite rellenar una pequeña bombona, utilizada por el paciente para sus desplazamientos, a modo de mochila.

Finalmente, los nuevos concentradores portátiles, con un peso inferior a 1,5 kg, disponen de una pequeña batería que puede recargarse incluso en el mechero del coche, permitiendo una larga autonomía fuera de casa.

Sobre Carburos Médica-Grupo Air Products
Compañía pionera en la innovación de mejoras para los pacientes con enfermedades respiratorias, Carburos Médica cuenta con más de 65 años de experiencia en el sector sanitario y es líder nacional en gases medicinales y en servicios sanitarios a domicilio. Su mentalidad fundamentalmente sanitaria le hace única dentro del sector gasista de nuestro país, explorando y desarrollando nuevos caminos que, en colaboración con diferentes socios, beneficien la salud y calidad de vida de la sociedad.
Air Products presta servicio a clientes en los mercados tecnológico, energético, sanitario e industrial de todo el mundo, ofreciendo una oferta global de productos, servicios y soluciones en gases atmosféricos, especiales y de proceso, así como materiales de alto rendimiento e intermedios químicos.

Fundada en 1940, Air Products es líder en mercados clave como semiconductores, refinería de hidrógeno, servicios de asistencia sanitaria, licuefacción de gas natural y recubrimientos avanzados y adhesivos. La compañía es reconocida por su cultura innovadora, su excelencia operacional y su compromiso con la seguridad y el medioambiente y está incluida en el Dow Jones Sustainability y el FTSE4Good Indices. La compañía opera en más de 40 países y cuenta con más de 18.900 empleados en todo el mundo, con unos ingresos en el año fiscal de 2009 de 8,3 billones de dólares. Más información en www.airproducts.com.

Air Products to Build New World-Scale Air Separation Unit in Texas

Thu, 29 Oct 2009 00:00:00 -0400

Air Products (NYSE: APD) today announced plans to build a new world-scale air separation unit (ASU) at its La Porte, Texas industrial gases facility. The energy efficient ASU will replace older assets at the site and provide benefits to customers through higher-reliability pipeline oxygen and nitrogen supply, and enhanced production of merchant and electronics products including argon and xenon. The new ASU is to be on-stream in October 2011.

“This world-scale ASU at La Porte will serve customers across Air Products’ three major business areas of Tonnage Gases, Merchant Gases and Electronics and increase supply security and reliability. It will deliver significant productivity gains through decreased energy consumption and operating costs and supports the company’s sustainability goals,” said Stephen Jones, senior vice president and general manager–Tonnage Gases, Equipment and Energy at Air Products.

The new La Porte ASU will ensure the long-term operational viability and customer supply security of one of Air Products’ key liquid argon sources for the North American market. Argon is used primarily for welding, electronics, steel and metals processing applications. The plant also will expand Air Products’ xenon production capacity and improve customer supply security and reliability. Xenon continues to grow as a key material used in the etching steps of semiconductor manufacturing, and the additional volume will support growth in the emerging technologies of plasma display and other lighting applications which depend on xenon’s special properties.

The La Porte ASU is part of Air Products’ extensive Gulf Coast network of industrial gas facilities, pipelines and distribution assets. In addition to its oxygen, nitrogen and argon businesses, Air Products has the leading hydrogen position in the region comprised of numerous production facilities and over 450 miles of pipelines reaching from the Houston Ship Channel in Texas to Lake Charles, Louisiana, and from the city of Plaquemine, Louisiana to Chalmette, east of New Orleans.

Air Products (NYSE:APD) serves customers in industrial, energy, technology and healthcare markets worldwide with a unique portfolio of atmospheric gases, process and specialty gases, performance materials, and equipment and services. Founded in 1940, Air Products has built leading positions in key growth markets such as semiconductor materials, refinery hydrogen, home healthcare services, natural gas liquefaction, and advanced coatings and adhesives. The company is recognized for its innovative culture, operational excellence and commitment to safety and the environment. In fiscal 2009, Air Products had revenues of $8.3 billion, operations in over 40 countries, and 18,900 employees around the globe. For more information, visit:
> www.airproducts.com

NOTE: This release may contain forward-looking statements. Actual results could vary materially, due to changes in current expectations.

Air Products Announces North American Price Increase for Liquid and Bulk Industrial Gas Products

Tue, 15 Sep 2009 00:00:00 -0400

Effective October 1, 2009, or as contracts permit, Air Products (NYSE:APD) will increase pricing and monthly service charges as follows for merchant customers in North America for the following products:

liquid oxygen, liquid nitrogen, liquid argon, liquid and bulk hydrogen by 4% to 8%; and
liquid and bulk helium by 5% to 10%.

Some price adjustments may be outside of these ranges based on other specific situations.

This pricing initiative is in response to higher operating costs related to running plants with significantly lower product demand, in addition to both higher energy costs and overall increases associated with the production and distribution of merchant gas products.

NOTE: This release may contain forward-looking statements. Actual results could vary materially, due to changes in current expectations.

0518-Air-Products-Sells-Three-US-Healthcare-Businesses-to-Landauer-Metropolitan

Mon, 18 May 2009 00:00:00 -0400

Air Products (NYSE:APD) today announced it has sold three of its U.S. healthcare businesses to Landauer-Metropolitan, Inc. (LMI), the largest provider of durable medical equipment, respiratory and infusion services in the northeast, based in Mount Vernon, N.Y. Terms of the deal were not disclosed.

The sale includes Air Products’ ownership interests in certain of the companies previously operated as part of the Air Products Healthcare LLC Group, namely Genox Homecare, serving Connecticut; Mid-Atlantic Healthcare, serving Maryland, Washington, D.C., and northern Virginia; and Young’s Medical Equipment, serving eastern and central Pennsylvania and New Jersey. There are approximately 220 employees, 15 locations and more than 36,000 patients associated with these businesses.

Last September, Air Products completed the sale of two other U.S. healthcare businesses to LMI, including A&J Care in New York and COPD Services in New Jersey.

Earlier this month, Air Products announced the sale of all of its U.S. home infusion therapy services business and some elements of its respiratory and home medical equipment business to OptionCare Enterprises, Inc., a subsidiary of Walgreen Co. These businesses included American Homecare Supply, Georgia; Ultra Care and Dependicare, Chicago metropolitan area; Rx Pharmacy and Mosso’s Medical Supply Company in western Pennsylvania; Collins I.V. Care, Connecticut, and Air Products Healthcare Pharmacy, Lehigh Valley, Philadelphia metropolitan and southern New Jersey.

Air Products expects to sell its remaining U.S. healthcare businesses by the end of the company’s fiscal year in September.

Air Products (NYSE:APD) serves customers in industrial, energy, technology and healthcare markets worldwide with a unique portfolio of atmospheric gases, process and specialty gases, performance materials, and equipment and services. Founded in 1940, Air Products has built leading positions in key growth markets such as semiconductor materials, refinery hydrogen, home healthcare services, natural gas liquefaction, and advanced coatings and adhesives. The company is recognized for its innovative culture, operational excellence and commitment to safety and the environment. Air Products had fiscal 2008 revenues of $10.4 billion, operations in over 40 countries, and 21,000 employees around the globe. For more information, visit www.airproducts.com.

NOTE: This release may contain forward-looking statements. Actual results could vary materially, due to changes in current expectations.

Air Products Sells Major Portion of U.S. Healthcare Operations to Walgreens

Tue, 05 May 2009 00:00:00 -0400

Air Products (NYSE: APD) today announced it has sold all of its U.S. home infusion therapy services business and some elements of its respiratory and home medical equipment business to OptionCare Enterprises, Inc., a subsidiary of Walgreen Co. Terms of the agreement were not disclosed.

The transaction includes Air Products’ ownership interests in certain of the companies previously operated as part of the Air Products Healthcare LLC Group, notably the home infusion therapy business of American Homecare Supply, Georgia (serving Atlanta and northern Georgia); Ultra Care and Dependicare (Chicago metropolitan area); Rx Pharmacy Services and Mosso’s Medical Supply Company (western Pennsylvania and Pittsburgh metropolitan area); Collins I.V. Care (Connecticut); and Air Products Healthcare Pharmacy (Lehigh Valley, Philadelphia metropolitan area and southern New Jersey).

The transaction represents nearly 50 percent of the remaining Air Products Healthcare Group portfolio and includes 15locations with 550 employees serving about 25,000 patients.

About OptionCare Enterprises, Inc.
Walgreens-OptionCare delivers quality, compassionate, patient-focused home infusion, respiratory/oxygen and medical equipment services through more than 100 accredited home care facilities in 36 states. The company’s clinical programs provide the expert care coordination expected by patients, physicians and insurance plans for successful outcomes.

About Air Products
Air Products (NYSE:APD) serves customers in industrial, energy, technology and healthcare markets worldwide with a unique portfolio of atmospheric gases, process and specialty gases, performance materials, and equipment and services. Founded in 1940, Air Products has built leading positions in key growth markets such as semiconductor materials, refinery hydrogen, home healthcare services, natural gas liquefaction, and advanced coatings and adhesives. The company is recognized for its innovative culture, operational excellence and commitment to safety and the environment. Air Products had fiscal 2008 revenues of $10.4 billion, operations in over 40 countries, and 21,000 employees around the globe. For more information, visit www.airproducts.com.

NOTE: This release may contain forward-looking statements. Actual results could vary materially, due to changes in current expectations.

El servicio CryoEase de Carburos Metalicos una solucion para el suministro de gases

Mon, 23 Feb 2009 00:00:00 -0500

Carburos Metálicos, Grupo Air Products, cuenta con el servicio CryoEase® para el suministro de gases como el nitrógeno, oxígeno, argón o dióxido de carbono, entre otros. Gracias a este servicio se puede instalar un depósito compacto que proporciona el gas a la presión adecuada y de forma ininterrumpida, incluso durante la recarga de los depósitos.

Al utilizarse un solo depósito en vez de los habituales bloques de botellas, se consigue una reducción del espacio necesario. Por poner un ejemplo, un pequeño depósito de líquido puede contener el equivalente a 16 botellas a alta presión ocupando un espacio más reducido. Asimismo, al instalarse un sólo depósito se mejora la seguridad y eficacia, ya que el gas se canaliza directamente al punto de utilización, se evita el riesgo de contaminación cruzada al ser recipientes de uso exclusivo, y las entregas, que disminuyen respecto a las botellas, no requieren de la intervención ni manipulación por parte del cliente.

Otra de las ventajas del sistema CryoEase^® es su amplia gama de depósitos que van de los 25 a los 2.000 litros al igual que su fácil instalación. Para su ubicación normalmente no es necesaria ninguna cimentación especial, ni licencia de obra y no requiere de corriente eléctrica ni otros servicios.

Abastecimiento automático
Su abastecimiento se realiza de forma automática sin necesidad de realizar ningún pedido con un camión cisterna de Carburos Metálicos de dimensiones reducidas que acude cuando el nivel de gas en el depósito baja hasta un nivel preestablecido. Igualmente, los clientes cuentan con el asesoramiento de un profesional de la compañía en materia de selección de depósito, diseño del sistema de gas, instalación, revisión, mantenimiento y seguridad.

Sobre Carburos Metálicos
Carburos Metálicos se constituyó en 1897. Desde entonces ha registrado un crecimiento constante que le ha llevado a liderar el sector de gases industriales y de uso medicinal en España. La empresa cuenta con un equipo de más de 1.000 profesionales, 15 plantas de producción, 2 laboratorios de gases de alta pureza, 41 centros propios y más de 200 puntos de distribución y delegaciones repartidos por todo el territorio nacional. Carburos Metálicos forma parte del Grupo Air Products desde 1995.

Sobre Air Products
Air Products presta servicio a clientes en los mercados tecnológico, energético, sanitario e industrial de todo el mundo, proporcionándoles una oferta global de productos, servicios y soluciones en gases atmosféricos, especiales y de proceso, así como materiales de alto rendimiento e intermedios químicos. Fundada en 1940, Air Products es líder en mercados clave como semiconductores, producción de hidrógeno, servicios de asistencia sanitaria, licuefacción de gas natural y recubrimientos avanzados y adhesivos. La compañía es reconocida por su cultura innovadora, su excelencia operacional y su compromiso con la seguridad y el medioambiente. Air Products tiene unos ingresos anuales de más de 10 billones de dólares, opera en más de 40 países, y cuenta con 21.000 empleados en todo el mundo. Para más información, www.airproducts.com.

Air Products Announces North American Price Increase for Liquid and Bulk Industrial Gas Products

Mon, 15 Sep 2008 00:00:00 -0400

Effective October 1, 2008, or as contracts permit, Air Products (NYSE:APD) will increase schedule pricing on liquid oxygen and liquid nitrogen by eight percent, liquid argon and liquid and bulk hydrogen by 12 percent, and liquid and bulk helium by 15 to 30 percent for merchant customers in North America.

The pricing initiatives are needed to address continued cost pressures and the need for ongoing investment in infrastructure to improve operating efficiencies. These cost pressures include escalating material, labor, and energy costs associated with the production and distribution of merchant gas products, and to support capital investment required to meet current and future demand.

NOTE: This release may contain forward-looking statements. Actual results could vary materially, due to changes in current expectations.

Air Products Completes Sale of A&J Care and COPD Services to Landauer Metropolitan

Fri, 05 Sep 2008 00:00:00 -0400

Air Products (NYSE:APD) has completed the sale of its U.S. healthcare businesses, A&J Care and COPD Services, to Landauer Metropolitan Inc. (LMI), the largest provider of durable medical equipment, respiratory and infusion services in the northeast, based in Mount Vernon, NY. Terms of the deal were not disclosed.

Air Products announced in July plans to sell its U.S. Healthcare business and begin reporting the business as a discontinued operation. As part of that announcement, the company said it had reached preliminary agreement to sell A&J Care’s metropolitan New York operations in Glendale and Peekskill and COPD Services’ New Jersey operations in Runnemede, Cape May Courthouse and Cedar Grove. The 180 employees associated with these businesses have been offered employment with LMI.

“We are pleased to complete this sale to LMI as they are a large and reputable supplier of homecare products and services,” said Phil Sproger, vice president and general manager, U.S. Healthcare. “We wish our employees well as they continue their employment with LMI and thank them for their hard work and dedication under difficult circumstances.”

Air Products (NYSE:APD) serves customers in industrial, energy, technology and healthcare markets worldwide with a unique portfolio of atmospheric gases, process and specialty gases, performance materials, and equipment and services. Founded in 1940, Air Products has built leading positions in key growth markets such as semiconductor materials, refinery hydrogen, home healthcare services, natural gas liquefaction, and advanced coatings and adhesives. The company is recognized for its innovative culture, operational excellence and commitment to safety and the environment. Air Products has annual revenues of $10 billion, operations in over 40 countries, and 22,000 employees around the globe. For more information, visit www.airproducts.com.

NOTE: This release may contain forward-looking statements. Actual results could vary materially, due to changes in current expectations.

Kundeninformation: Preisanpassung für Flüssiggase zum 1. Oktober 2008

Mon, 01 Sep 2008 00:00:00 -0400

Die Air Products GmbH passt die Preise für tiefkalte verflüssigte Gase (Stickstoff, Sauerstoff und Argon) sowie für Wasserstoff zum 1. Oktober 2008 an. Diese Maßnahme ist eine Reaktion auf die deutlich gestiegenen Kosten der energieintensiven Erzeugung und Distribution von Industriegasen, in der sich die anhaltenden Preissteigerungen für Strom und Dieseltreibstoff niederschlagen. Alle Anzeichen lassen mittel- und langfristig weitere Kostensteigerungen erwarten. Ursache hierfür ist unter anderem die steigende globale Nachfrage.

Weitere Informationen zu den genannten Kostenentwicklungen finden Sie hier:

Strompreisindex des Verbandes der industriellen Energie- und Kraftwirtschaft e.V (VIK)
E.ON-Vorstand: Energiepreisentwicklung war in keinem Szenario enthalten
Bundesverband der Deutschen Industrie e.V. (BDI) zur Strompreisentwicklung
Dieselpreisentwicklung laut Bundesverband Güterkraftverkehr Logistik und Entsorgung (BGL) e.V.
Handelsblatt: Öl bleibt auf lange Sicht teuer

Air Products (Air Products and Chemicals, Inc.) bietet seinen Kunden aus Industrie und Handel ein weltweit einzigartiges Portfolio von Produkten, Dienstleistungen und Lösungen. Das Angebot umfasst Industrie-, Prozess- und Spezialgase sowie chemische Werkstoffe und Zwischenprodukte. Dazu gehören insbesondere Materialien für die Halbleiterfertigung, Wasserstoff- und Erdgasprodukte, Polymere und Klebstoffe sowie medizinische Gase und Dienstleistungen im Bereich der stationären und häuslichen Patientenbetreuung.

Seit seiner Gründung im Jahr 1940 hat Air Products sein Angebot kontinuierlich ausgebaut und sich dadurch eine führende Stellung in bedeutenden Wachstumsmärkten erarbeitet. Im Mittelpunkt der Unternehmenskultur stehen Innovation, effiziente Prozesse und ein umfassendes Sicherheits- und Umweltbewusstsein. Air Products erzielt mit rund 22.000 Mitarbeitern in mehr als 40 Ländern einen Jahresumsatz von rund zehn Milliarden US-Dollar. Weitere Informationen finden Sie unter www.airproducts.com.

Kontakt:
Air Products GmbH
Hüttenstrasse 50
45527 Hattingen
Deutschland
Tel.: +49 (0) 2324 / 689 0
Fax: +49 (0) 2324 / 689 100

Air Products Announces Plans to Sell Its U.S. Healthcare Business; Will Record Impairment Charge for Fiscal Third Quarter

Tue, 22 Jul 2008 00:00:00 -0400

Air Products (NYSE:APD) announced today that it is planning to sell its U.S. Healthcare business and will record an impairment charge of approximately $315 million ($237 million after-tax) in its fiscal 2008 third quarter results, ended June 30. The company plans to report the U.S. Healthcare business as a discontinued operation beginning in the fiscal fourth quarter and will continue to operate and serve patients until the business is transitioned to a new owner.

In 2007, the company implemented a number of significant actions to improve the performance of its U.S. Healthcare business, including changes in management, a product and service offering simplification program, and other measures to drive earnings growth and improve profitability. During 2008, the business continued to underperform. As a result, in April 2008, Air Products disclosed that it was evaluating its strategic options for the business. Based on a review of the market and competitive conditions, the company determined that the U.S. Healthcare business no longer fits its business portfolio. At its July meeting, the company’s Board of Directors authorized management to pursue the sale of the business, and the company is in discussions with potential buyers.

Chairman, President and Chief Executive Officer John E. McGlade, said, “Our U.S. Healthcare employees have worked very hard to execute our plan to increase volumes and reduce costs. Unfortunately, despite progress in a number of areas, the U.S. business is still not meeting expectations. At this time, we believe the decision to sell this business is in the best interest of our shareholders. This in no way affects our healthcare operations outside of the U.S, which continue to perform well and remain a core component of our strategy moving forward.”

Air Products is also announcing that it has reached preliminary agreement to sell its U.S. Healthcare businesses in the metropolitan New York area and in New Jersey, including its A&J Care locations in Glendale and Peekskill, New York and its COPD Services locations in Runnemede, Cape May Courthouse and Cedar Grove, New Jersey. This sale is expected to be completed by the end of the fiscal year.

Air Products has been in the U.S. healthcare market since October 2002 when it acquired American Homecare Supply. The company subsequently made additional acquisitions, growing its U.S. sales to $271 million in fiscal 2007 by providing respiratory therapies, home medical equipment and infusion services to patients in their homes. The U.S. Healthcare business operates in over 80 locations, has approximately 1,700 employees, and serves 120,000 patients, mainly throughout the eastern half of the U.S.

Air Products will continue to serve its hospital and magnetic resonance imaging customers in the U.S. through its Merchant Gases segment. These institutional healthcare businesses were never included in the Healthcare segment.

Air Products will release its fiscal 2008 third quarter financial results on Wednesday, July 23, 2008, and will host teleconference at 10:00 a.m. EDT. The teleconference will be open to the public and the media in listen-only mode by telephone and Internet broadcast.

Live teleconference: (719) 325-4783
Passcode: 1115514
Internet broadcast/slides:
www.airproducts.com/Invest/financialnews/Earnings_Releases/Teleconference.htm

Air Products (NYSE:APD) serves customers in industrial, energy, technology and healthcare markets worldwide with a unique portfolio of atmospheric gases, process and specialty gases, performance materials, and equipment and services. Founded in 1940, Air Products has built leading positions in key growth markets such as semiconductor materials, refinery hydrogen, home healthcare services, natural gas liquefaction, and advanced coatings and adhesives. The company is recognized for its innovative culture, operational excellence and commitment to safety and the environment. Air Products has annual revenues of $10 billion, operations in over 40 countries, and 22,000 employees around the globe. For more information, visit www.airproducts.com.

NOTE: This document contains “forward-looking statements” within the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. These forward-looking statements are based on management’s reasonable expectations and assumptions as of the date of this document regarding important risk factors. Actual performance and financial results may differ materially from projections and estimates expressed in the forward-looking statements because of many factors, including, without limitation, overall economic and business conditions different than those currently anticipated; future financial and operating performance of major customers and industries served by the Company; the impact of competitive products and pricing; interruption in ordinary sources of supply of raw materials; the ability to recover unanticipated increased energy and raw material costs from customers; costs and outcomes of litigation or regulatory activities; consequences of acts of war or terrorism impacting the United States’ and other markets; the effects of a pandemic or a natural disaster; the ability to attract, hire and retain qualified personnel in all regions of the world where the company operates; charges related to portfolio management, goodwill recoverability, business restructuring and cost reduction actions; the success of implementing cost reduction programs; the timing, impact, and other uncertainties of future acquisitions or divestitures; unanticipated contract terminations or customer cancellation or postponement of projects or sales; significant fluctuations in interest rates and foreign currencies from that currently anticipated; the continued availability of capital funding sources in all of the company's foreign operations; the impact of new or changed environmental, healthcare, tax or other legislation and regulations in jurisdictions in which the Company and its affiliates operate; the impact of new or changed financial accounting standards; and the timing and rate at which tax credits can be utilized. The Company disclaims any obligation or undertaking to disseminate any updates or revisions to any forward-looking statements contained in this document to reflect any change in the Company’s assumptions, beliefs or expectations or any change in events, conditions or circumstances upon which any such forward-looking statements are based.

Der Rekordstand der Ölpreise macht eine Anpassung des Energiekostenzuschlags zum 1. August 2008 notwendig

Thu, 26 Jun 2008 00:00:00 -0400

Die stetige Anhebung des Rohölpreises in den vergangenen Monaten hat einen immensen Anstieg der Betriebskosten in der gesamten Versorgungskette sowohl bei den technischen als auch bei den Spezialgasen zur Folge.

Energie ist ein essentieller Rohstoff innerhalb des Gasgeschäfts; sie wird für den Luftzerlegungsprozess, bei dem Luft in ihre Gasbestandteile zerlegt wird, ebenso benötigt wie für die Hochdruckbefüllung von Gasflaschen und Bündeln oder die Lieferung der Gase an Lieferstellen und Kunden.

Trotz unserer Energiesparprogramme sehen wir uns aufgrund der aktuellen Entwicklung an den Energiemärkten daher gezwungen, ab dem 1. August 2008 den für alle Gasflaschen, Bündel, Minitanks und CryoEase ®-Produkte geltenden Energiekostenzuschlag zu erhöhen.

Alle anderen Preise und Vereinbarungen bleiben davon unberührt .

Diese Nachricht gilt für Kunden, die Air Products-Flaschengase und/oder CryoEase ®-Produkte beziehen.

Pressekontakt:
Sascha Stoltenow
Script Corporate+Public Communication
Tel.: 06171/2847-280
Email: s.stoltenow@script-com.de

Air Products To Update Product and Energy Surcharges for Liquid and Bulk Industrial Gas Products in North America

Mon, 23 Jun 2008 00:00:00 -0400

Effective July 1, 2008, Air Products (NYSE:APD) will update product and energy surcharges for all of its liquid and bulk products in North America. These updates are being implemented as a result of the continued extraordinary cost increases for diesel fuel, natural gas and power during the last few months. Diesel fuel, natural gas and power make up a substantial portion of the costs incurred to produce and deliver industrial gases.

Air Products (NYSE:APD) serves customers in industrial, energy, technology and healthcare markets worldwide with a unique portfolio of atmospheric gases, process and specialty gases, performance materials, and equipment and services. Founded in 1940, Air Products has built leading positions in key growth markets such as semiconductor materials, refinery hydrogen, home healthcare services, natural gas liquefaction, and advanced coatings and adhesives. The company is recognized for its innovative culture, operational excellence and commitment to safety and the environment. Air Products has annual revenues of $10 billion, operations in over 40 countries, and 22,000 employees around the globe. For more information, visit www.airproducts.com.

NOTE: This release may contain forward-looking statements. Actual results could vary materially, due to changes in current expectations.

Air Products Announces North American Price Increase for Liquid and Bulk Helium Products

Mon, 03 Mar 2008 00:00:00 -0500

Effective April 1, 2008, or as contracts permit, Air Products (NYSE:APD) will increase prices on liquid and bulk helium by a minimum of 20 percent for merchant customers in North America.

The pricing initiatives are needed to cover escalating material, labor, and energy costs associated with the production and distribution of its helium products and additional capital investment required to meet current and future demand.

NOTE: This release may contain forward-looking statements. Actual results could vary materially, due to changes in current expectations.

Kundeninformation Anpassung des GGVS Mautsatzes zum 1 Marz 2008

Wed, 27 Feb 2008 00:00:00 -0500

Anhaltende Kostensteigerungen in Vertrieb und Logistik erhöhen den Kostendruck auf die Air Products GmbH. Insbesondere die folgenden Entwicklungen wirken sich sehr belastend auf die Distribution von Industriegasen aus:

Gestiegene Dieselpreise

Laut Statistischem Bundesamt erreichten die Dieselpreise bei Abgabe an Großverbraucher im November 2007 ihren historischen Höchstwert von 103,96 EUR pro 100 Liter. Im Jahresvergleich (Dezember 2006 - Dezember 2007) stiegen die Dieselpreise sogar um 18,2% von 87,62 EUR auf 103,56 EUR pro 100 l.

Erhöhte Mautgebühren

Die Mautgebühren wurden zum 1. September 2007 um 8,9% von durchschnittlich 12,4 Cent auf 13,5 Cent pro Kilometer angehoben. Darüber hinaus hat das Bundesministerium für Verkehr, Bau und Stadtentwicklung (BMVBS) bereits jetzt die nächste Mauterhöhung zum 1. Oktober 2008 um bis zu 52% je nach Emissionsklasse angekündigt.

Reduzierung der Arbeitszeiten für Kraftfahrer

Seit April 2007 dürfen Kraftfahrer laut Arbeitszeitgesetz nur noch maximal 48 anstelle der bisherigen 60 Stunden pro Woche arbeiten. Diese Neuregelung stellt eine erhebliche Kostenbelastung dar, da der verkürzte Arbeitszeitrahmen zusätzliches Fahrerpersonal erfordert.

Selbst ständige Prozessoptimierungen und Rationalisierungsmaßnahmen können diese zusätzlichen Belastungen nicht völlig kompensieren. Wir sehen uns deshalb gezwungen, Teile dieser Kostensteigerungen an unsere Kunde weiterzugeben und den GGVS/Mautsatz für unsere tiefkalten verflüssigten Gase (Sauerstoff, Stickstoff und Argon) sowie für Wasserstoff anzupassen.

Weitere Informationen finden Sie hier:

Dieselpreisentwicklung laut Bundesverband Güterkraftverkehr Logistik und Entsorgung (BGL) e.V.
Pressemitteilung TOLLCOLLECT zur Erhöhung der Mautgebühren
Informationen zur Änderung des Arbeitszeitgesetzes von der Berufsgenossenschaft für Handel und Warendistribution (BGHW)
Tagesspiegel Presseartikel „Tausende LKW-Fahrer gesucht“

Air Products and Matheson Tri-Gas to Form Joint Venture to Build and Operate New Wyoming Helium Plant

Wed, 17 Oct 2007 00:00:00 -0400

Air Products (NYSE: APD) and Matheson Tri-Gas, Inc., a member of the Taiyo Nippon Sanso Corporation (TNSC) group, today announced their intention to jointly build and operate a liquid helium production plant near Big Piney, Wyoming. The plant, designed to produce 200 million standard cubic feet per year at start-up, with expectations for future capacity expansion, would process crude helium produced by a natural gas processing facility that would be owned by Cimarex Energy Co. (NYSE: XEC) and their partner, Riley Ridge LLC.

The Cimarex facility would process natural gas from the Riley Ridge Field in Wyoming, the second largest helium-rich natural gas field in the United States. Riley Ridge is believed to contain sufficient helium reserves to support production for decades. Production at the new Wyoming plant is anticipated to commence in 2009.

Air Products, the global leader in helium production, has pioneered many of the helium extraction, production, distribution and storage technologies used in the industry today. Air Products maintains the world’s largest helium production and distribution system and operates numerous facilities around the world.

“We are enthusiastic about developing the helium reserves at Riley Ridge. Bringing on this new source, with very long-lived helium reserves, will enable us to further diversify our helium supply and enhance our ability to reliably serve our worldwide customers,” said John Van Sloun, general manager, Helium and Rare Gases for Air Products. “We continue to see tightness in the supply of helium in the global market. The initial helium volumes expected from Riley Ridge in 2009 are relatively small, but this important new facility can produce additional product to help meet growing global demand.”

Matheson Tri-Gas Global Helium was formed in September 2006 when its parent company, TNSC, acquired the helium assets that were divested in connection with Linde AG’s acquisition of The BOC Group, plc. TNSC is the leading helium supplier in Japan, and is one of only six industrial gas companies in the world with direct access to helium sources.

“Taiyo Nippon Sanso purchased a ‘sold out’ helium business from Linde with limited ability to grow. Helium from the Riley Ridge Project will improve our ability to supply existing customers and provide the opportunity to grow the business beginning in 2009. Moreover, Matheson Tri-Gas’ participation in the Riley Ridge Project gives us additional credibility as a competitor in the global helium business,” said Phil Kornbluth, executive vice president, Global Helium for Matheson Tri-Gas.

Upon completion, the Wyoming helium production plant will be the 10th liquid helium plant operating in the United States, and the first new U.S. facility since 2000. It is expected to employ approximately 8-10 people after start-up.

Helium is used in many unique and valued applications including: magnetic resonance imaging (MRI); lifting for high altitude scientific research balloons, blimps and party balloons; fiber optics and semiconductor manufacturing; metallurgy; breathing atmospheres for deep diving or unique blood gas medical mixtures; analytical chemistry; pressurizing and purging pipes, vessels, and other critical equipment; leak detection; and other advanced applications.

About Air Products

Air Products (NYSE:APD) serves customers in industrial, energy, technology and healthcare markets worldwide with a unique portfolio of atmospheric gases, process and specialty gases, performance materials, and equipment and services. Founded in 1940, Air Products has built leading positions in key growth markets such as semiconductor materials, refinery hydrogen, home healthcare services, natural gas liquefaction, and advanced coatings and adhesives. The company is recognized for its innovative culture, operational excellence and commitment to safety and the environment. Air Products has annual revenues of $9 billion, operations in over 40 countries, and over 20,000 employees around the globe. For more information, visit www.airproducts.com.

About Matheson Tri-Gas

Matheson Tri-Gas, Inc., is a single source provider of industrial and specialty gases, including bulk and cylinder gases, gas handling equipment, high performance purification systems, and related hard goods. The Company also provides support services, engineering services, and systems management services to analytical laboratories and semiconductor manufacturers worldwide. As a member of the Taiyo Nippon Sanso Corporation group, Matheson Tri-Gas, Inc., is part of a worldwide industrial gas organization focusing on being the single source provider for global customer requirements. For more information, visit www.matheson-trigas.com.

NOTE: This release may contain forward-looking statements. Actual results could vary materially, due to changes in current expectations.

Matheson Tri-Gas Contacts:
Beth Sullivan
Tel: (215) 648-4026
E-mail: bsullivan@matheson-trigas.com

Christine Scully
Tel: (201) 825-1331
E-mail: christine.scully@verizon.net

Air Products Announces North American Price Increase For Several Liquid and Bulk Industrial Gas Products

Mon, 17 Sep 2007 00:00:00 -0400

Effective October 1, 2007, or as contracts permit, Air Products (NYSE:APD) will increase schedule pricing on bulk helium by 30 percent, liquid oxygen and liquid nitrogen by eight percent, liquid and bulk hydrogen by 12 percent, and liquid argon by 12 percent for merchant and government customers in North America.

The pricing initiatives are needed to address continued cost pressures and the need for ongoing investment in infrastructure to increase operating rates. These cost pressures include escalating material, labor, and energy costs associated with the production and distribution of its merchantgas products, and to support capital investment required to meet current and future demand.

NOTE: This release may contain forward-looking statements. Actual results could vary materially, due to changes in current expectations.

Air Products Reaches Microbulk Solutions Milestone with 10,000th Installation

Thu, 28 Jun 2007 00:00:00 -0400

Air Products (NYSE: APD) achieved a milestone in May with the 10,000th customer installation of its innovative Microbulk Solutions for small volume industrial gas customers. The installation of Microbulk Solutions at a customer manufacturing facility located in Georgia marked the achievement of the global product offering first introduced in the United States in 2005, and offered in Europe prior to 1990. Microbulk Solutions is a novel gas supply and services option that provides the most technically-advanced and cost-effective alternative to traditional cylinder gas packaging in the marketplace.

“Microbulk delivery service and on-site storage and blending systems are very popular and have reached the 10,000th installation because the offering brings the advantages of bulk supply to operations with less than traditional bulk delivery volumes. At the 10,000th installation, Microbulk was the answer for our customer’s argon needs for vacuum furnaces. Whether it is argon or nitrogen for heat-treating furnace atmospheres, nitrogen or oxygen for laser-assist gases, or argon and argon blends for weld shielding, Microbulk supply can mean efficient, economical and reliable supply for small-volume users,” said John Tapley, Microbulk business development manager at Air Products.

Air Products’ Microbulk Solutions has had an impact for several markets including metals processing, biotechnology, foods, electronics and healthcare industries, and for applications with relatively small volume gas requirements. The service appeals to small-volume customers by virtually eliminating cylinder handling and reducing the number of product deliveries.

Microbulk tank trucks provide fast fills into storage tanks that are designed to offer customers a range of flexible supply options. They feature automatic fill shut-off devices; computer telemetry that remotely monitors tank levels, or programmable digital liquid level gauges to help customers monitor their inventory; and tanks with enhanced thermal qualities to limit product loss during periods of little or no use. Microbulk Solutions provide a much simplified supply chain option over the former gas supply practice of many industries’ processing operations that historically relied on high-pressure cylinders and dewars―a labor-intensive approach often resulting in wasted residual gas and the potential for interrupted supply, cross-contamination and safety issues.

Air Products (NYSE:APD) serves customers in industrial, energy, technology and healthcare markets worldwide with a unique portfolio of atmospheric gases, process and specialty gases, performance materials, and equipment and services. Founded in 1940, Air Products has built leading positions in key growth markets such as semiconductor materials, refinery hydrogen, home healthcare services, natural gas liquefaction, and advanced coatings and adhesives. The company is recognized for its innovative culture, operational excellence and commitment to safety and the environment and is listed in the Dow Jones Sustainability and FTSE4Good Indices. The company has annual revenues of $9 billion, operations in over 40 countries, and over 20,000 employees around the globe. For more information, visit www.airproducts.com.

NOTE: This release may contain forward-looking statements. Actual results could vary materially, due to changes in current expectations.

Air Products Forms Joint Venture with CNOOC Oil Base Group Ltd. to Serve China's Fast-Growing Fujian Province

Tue, 22 May 2007 00:00:00 -0400

Air Products (NYSE: APD) today announced that it has formed a joint venture with CNOOC Oil Base Group Ltd., which is a wholly owned subsidiary of China National Offshore Oil Corporation (CNOOC), one of the largest state-owned oil companies and the leading offshore oil and gas producer in the country.

The joint venture will build and operate an air separation unit (ASU) and liquefier in Putian, Fujian Province, to produce liquid oxygen, nitrogen and argon by using cold energy from liquefied natural gas (LNG). It is the first application of LNG cold energy at an ASU plant in China.

Air Products will also build and operate the associated storage and distribution operations at the ASU plant to supply the liquid products to the local market in Fujian Province, a fast growing marketplace for industrial gases.

"This is the first use of cold energy to make industrial gas products in China. We find Air Products is the best partner for this effort because it is a leader in the LNG industry and has a proven track record in ASU plant design and in reliable and safe operation," said Mr. Meng Liming, general manager of CNOOC Oil Base Group Ltd. "Air Products also has the capabilities and expertise to market the products from this venture," added Mr. Meng.

Fujian Province plays a significant role in the dynamic pan-Pearl River Delta economic region. In 2006, it ranked ninth in the country for its industrial output. The electronics and petrochemical industries have become emerging pillars of Fujian's economy, and contributed nearly half of the total production value of Fujian's industry.

"We are deeply honored to partner with CNOOC and to be able to participate in this environmentally-beneficial project. The use of cold energy will significantly reduce power consumption in the industrial gas production process which helps protect the environment. We look forward to the successful partnership this venture will bring," said Bob Dixon, vice president and general manager of Global Merchant Gases at Air Products. "Our partnership with CNOOC and investment in Fujian Province will strengthen our supply position in this fast-growing industrial market in China."

The ASU plant in Putian, Fujian Province is expected to come on-stream in 2009.

Air Products (NYSE:APD) serves customers in industrial, energy, technology and healthcare markets worldwide with a unique portfolio of atmospheric gases, process and specialty gases, performance materials, and equipment and services. Founded in 1940, Air Products has built leading positions in key growth markets such as semiconductor materials, refinery hydrogen, home healthcare services, natural gas liquefaction, and advanced coatings and adhesives. The company is recognized for its innovative culture, operational excellence and commitment to safety and the environment and is listed in the Dow Jones Sustainability and FTSE4Good Indices. The company has annual revenues of US$9 billion, operations in over 40 countries, and over 20,000 employees around the globe. For more information, visit www.airproducts.com.

NOTE: This release may contain forward-looking statements. Actual results could vary materially, due to changes in current expectations.

Air Products Completes Purchase of BOC Gazy from Linde

Mon, 30 Apr 2007 00:00:00 -0400

Air Products (NYSE:APD) announced today that it has completed the acquisition of the industrial gas business of BOC Gazy Sp z o.o. from The Linde Group for 370 million euros or about $503 million. With this transaction, Air Products is now the leading industrial gas supplier in Central Europe’s fastest growing economy.

Air Products announced on January 8 its intention to acquire the BOC Gazy business and has since received clearance from the European and Polish regulatory authorities.

“This is a very compelling investment for Air Products,” said John McGlade, president and chief operating officer. “We now have the assets, infrastructure, people and management talent to take full advantage of the opportunities that come from having the leading position in one of the world’s fastest growing economies. Poland is the fourth largest recipient of foreign direct investment next to China, India and Brazil. Our combined operations are in the industrial heartland of the region where we can bring new applications and technology to drive quality, efficiency and performance in our customers’ businesses.”

The business, headquartered in Warsaw, has approximately 750 employees, five major industrial gas plants and six cylinder transfill facilities serving customers across a diverse range of industries, including chemicals, steel and base metals, among others. Combined with Air Products’ existing Polish business, 2006 sales were about 140 million euros or about $190 million.

Air Products operates in 15 countries throughout Europe, including the central and eastern European countries of the Slovak Republic, the Czech Republic, Russia and Poland. Total European sales in Air Products’ 2006 fiscal year were approximately $2.6 billion.

Air Products (NYSE:APD) serves customers in industrial, energy, technology and healthcare markets worldwide with a unique portfolio of atmospheric gases, process and specialty gases, performance materials, and equipment and services. Founded in 1940, Air Products has built leading positions in key growth markets such as semiconductor materials, refinery hydrogen, home healthcare services, natural gas liquefaction, and advanced coatings and adhesives. The company is recognized for its innovative culture, operational excellence and commitment to safety and the environment and is listed in the Dow Jones Sustainability and FTSE4Good Indices. The company has annual revenues of $9 billion, operations in over 40 countries, and over 20,000 employees around the globe. For more information, visit www.airproducts.com.

NOTE: This release contains “forward-looking statements” within the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. These forward-looking statements are based on management’s reasonable expectations and assumptions as of the date of this presentation regarding important risk factors. Actual performance and financial results may differ materially from those expressed in the forward-looking statements because of many factors, including those specifically referenced as future events or outcomes that the company anticipates as well as, among other things, overall economic and business conditions in Central and Eastern Europe and elsewhere different than those currently anticipated and demand for Air Products’ goods and services during that time; competitive factors in the industries in which it competes; natural or political interruption in ordinary sources of supply; the ability to recover unanticipated increased energy and raw material costs from customers; uninsured litigation judgments or settlements; changes in government regulations; consequences of acts of war or terrorism impacting the European and other markets; the effects of a pandemic or epidemic or a natural disaster; charges related to currently undetermined portfolio management and cost reduction actions; the success of implementing cost reduction programs or achieving synergies; the timing, impact, ability to complete and other uncertainties of future acquisitions or divestitures or unanticipated contract terminations; significant fluctuations in interest rates and foreign currencies from that currently anticipated; the impact of tax and other legislation and regulations in jurisdictions in which Air Products and its affiliates operate; the recovery of insurance proceeds; the impact of new financial accounting standards; and the timing and rate at which tax credits can be utilized. The company disclaims any obligation or undertaking to disseminate any updates or revisions to any forward-looking statements contained in this presentation to reflect any change in the company’s assumptions, beliefs or expectations or any change in events, conditions or circumstances upon which any such forward-looking statements are based.

Air Products Announces Pricing Actions for North American Merchant Gas Customers

Mon, 16 Apr 2007 00:00:00 -0400

Effective May 1, 2007, or as contracts permit, Air Products (NYSE:APD) will increase schedule pricing for liquid argon by 15 to 25 percent, liquid helium by 30 to 40 percent, and liquid-bulk oxygen and nitrogen by 10 to 15 percent for merchant customers in North America. Additionally, the company will increase its monthly service charge schedule pricing by 15 percent.

The pricing initiatives are being implemented to cover the continued escalating production costs of helium, argon, oxygen and nitrogen, as well as rising equipment replacement and maintenance costs for customer storage and supply systems.

NOTE: This release may contain forward-looking statements. Actual results could vary materially, due to changes in current expectations.

Mehr Mobilität für Sauerstoff-Patienten - Air Products Medical startet neuartiges Pauschalen-System in Deutschland

Tue, 13 Mar 2007 00:00:00 -0400

Zum 48. Kongress der „Deutschen Gesellschaft für Pneumologie und Beatmungsmedizin“ (DGP) (14. – 17. März 2007 in Mannheim) führt Air Products Medical in Deutschland ein neues Versorgungs- und Abrechnungs-Konzept für Sauerstoff-Patienten ein. Grundgedanke der so genannten Mobilitäts-Pauschalen ist es, die langfristige Sauerstoff-Versorgung auf die individuellen Bedürfnisse der Patienten zuzuschneiden. Und zwar unabhängig davon, ob sie eingeschränkt oder voll mobil sind.

„Bisher ist es in der Regel so, dass jede Änderung der Sauerstoff-Versorgung sowohl Zeit als auch Ressourcen gebunden hat und der Patienten seine Behandlung häufig als Verwaltungsakt erlebt hat.“ erklärt Heike Friedrich, Geschäftsführerin von Air Products Medical. „Mit den Mobilitätspauschalen passen wir dagegen unser Angebot ausgehend von der Indikation flexibel an die Anforderungen des Patienten an. Dieses Verfahren ist für alle Beteiligten schnell und unkompliziert.“

Komplettangebot mit hoher Transparenz

Die Mobilitäts-Pauschalen umfassen neben der Bereitstellung der medizintechnischen Geräte und der Sauerstoff-Versorgung die komplette Dienstleistungspalette inklusive Schulung, Einweisung, Wartung und Nachversorgung sowie einen 24-Stunden-Notdienst. Dieses Rund-um-Paket sichert die langfristige umfassende Versorgung des Patienten. Für Krankenkassen und Krankenversicherungen bietet das neue Angebot eine einfachere Handhabung und senkt nachhaltig den Verwaltungsaufwand. Auch auf ärztlicher Seite reduziert sich der Diagnostik- und Begutachtungsaufwand.
Die neue Mobilitäts-Pauschalen stellt Air Products Medical erstmals auf dem DGP vor (Congress Center Rosengarten Mannheim, Rosengartenplatz 2, 68161 Mannheim, Stand 102 im Obergeschoss).

Hintergrundinformationen „Mobilität“ und „Sauerstofflangzeit-Therapie“

Mit Sauerstofflangzeit-Therapie bezeichnet man die Verabreichung von Sauerstoff zu medizinisch-therapeutischen Zwecken. Die kommt bei einer Vielzahl an Atemwegs-, Lungen- und Herzerkrankungen zum Einsatz. In der Regel handelt es sich um chronische Krankheiten der Lunge, die eine zusätzliche Sauerstoff-Zufuhr bis zu 24 Stunden am Tag notwendig machen.
Die Behandlung mit Sauerstoff kann heute im häuslichen Umfeld umgesetzt werden und stellt damit eine sehr komfortable Therapie- und Versorgungsform dar. Als technische Hilfmittel kommen in der Regel so genannte Konzentratoren sowie Flüssig- und Druckgas-Systeme zum Einsatz. Moderne tragbare Systeme ermöglichen es dem Patienten mobil zu bleiben und fördern seine Lebensqualität deutlich.

Eine zentrale Rolle spielt dabei die Mobilität des Patienten. Regelmäßige Bewegung trainiert die Lunge und sorgt dafür, dass sie nicht weiter geschwächt wird. Eine gestärkte Lunge wiederum führt zu mehr Bewegungsfreiheit des Patienten. Mobilität verhindert somit eine Verschlechterung der Krankheit und kann so zur Senkung der Behandlungskosten beitragen.

Eine der häufigsten Indikationen für Sauerstofflangzeit-Therapie ist die so genannte COPD ("Chronic Obstructive Pulmonary Disease"). COPD ist eine Lungenerkrankung, bei der die Atemwege chronisch verengt sind. Häufigste Ursache für die Krankheit ist das Rauchen. In Deutschland leiden rund fünf Millionen Menschen an COPD; jährlich sterben hier etwa 25.000 Menschen. Die Weltgesundheitsorganisation (WHO) geht davon aus, dass COPD im Jahr 2020 in den Industrieländern die dritthäufigste Todesursache sein wird.

Hintergrundinformationen Air Products Medical
Air Products Medical ist weltweit einer der führenden Anbieter medizinischer Gase und medizinisch-technischer Dienstleistungen. Als Homecare Unternehmen bietet Air Products Medical umfassende Versorgungs- und Therapiekonzepte für Patienten in der häuslichen Umgebung.

Hierzu zählen neben der Sauerstofflangzeit-Therapie, die Heim-Beatmung, die Schlafapnoe-Therapie und die Patienten-Überwachung (Monitoring). Die Dienstleistung umfasst neben der Bereitstellung und Wartung der Medizintechnik-Geräte vor allem die Beratung, Betreuung und Schulung der Patienten und der pflegenden Angehörigen. Dazu gehört die Patienten-Überleitung aus dem Krankenhaus in die häusliche Umgebung genauso wie die gesamte Koordination und Abwicklung der Therapie mit der Krankenkasse oder Krankenversicherung.

Weltweit betreut Air Products Medical rund 300.000 Patienten. 150 Mitarbeiter versorgen in Deutschland über 50.000 Patienten. Damit gehört Air Products Medical nicht nur in Deutschland sondern weltweit zu den führenden Homecare-Unternehmen.

Air Products ist Mitglied im „Homecare Verband Medizinischer Sauerstoff e.V.“

Innovative Medizintechnologie bietet mehr Lebensqualitat

Wed, 07 Mar 2007 00:00:00 -0500

Als eines der ersten Unternehmen in Deutschland bietet Air Products Medical Schlafapnoe-Patienten eine umfassende Versorgungslösung auf Basis der neuesten Geräte-Generation von Respironics an.

Die neuen Geräte der BIPAP Auto M-Serie passen den Beatmungsdruck automatisch an die Beatmung des Patienten an und ermöglichen dem Patienten so eine wesentlich einfachere Ein- und Ausatmung. Mit den neuen Geräten lassen sich nun auch sehr komplexe Schlaf- und Atmungsmuster behandeln, die in der Vergangenheit nicht optimal therapiert werden konnten.

Besonders relevant ist das neue Angebot für Patienten mit variablen Ausprägungen der so genannten Schlafapnoe, also nächtlichen Atemstillstände. Bei diesen waren herkömmliche Therapie-Methoden in der Vergangenheit an ihre Grenzen gestoßen. Dank der neuen Technologie können nun auch diese Patienten sicher und komfortabel schlafen. Darüber hinaus sind die Geräte deutlich kleiner und leiser geworden und durch das neue Design sieht ihnen ihre Verwendung als medizintechnisches Therapie-Gerät kaum noch an.

„Die innovative Geräte-Technologie eröffnet vielen Patienten neue Therapiemöglichkeiten“, erläutert Heike Friedrich, Geschäftsführerin bei Air Products Medical. „Neben der besseren Lebensqualität für den Patienten gehen wir davon aus, dass in Verbindung mit unserer laufenden Betreuung auch die Kosten im Vergleich zu den bisher eingesetzten Verfahren sinken werden.“

Der höhere Komfort der neuen Technologie und die neuen Möglichkeiten und Indikationen, die damit behandelt werden können, führen zu einer besseren Akzeptanz beim Patienten und damit zu einer höheren Effizienz in der Therapie. Außerdem können kostspielige Folgerkrankungen wie Schlaganfall oder Herzinfarkt vermieden werden. Für eine erfolgreiche Therapie sind neben der Medizintechnik insbesondere die Unterstützung, Motivation und Beratung des Patienten sowie die regelmäßige Überprüfung des Therapiefortschritts mindestens ebenso wichtig. Daher legt Air Products Medical auf beide Bereiche großen Wert und bietet hier einen besonderen Service an:

„Mit unseren medizinischen Fachberatern haben wir speziell geschulte Mitarbeiter, die sich gerade in der Anwendung der Therapien besonders gut auskennen. Deshalb beraten sie den Patienten vor Ort in seinem häuslichen Umfeld, geben ihm Tipps im Umgang mit den Geräten und zeigen ihm Tricks und Kniffe wie es einfacher geht“, erläutert Heike Friedrich die integrierte Versorgungslösung von Air Products Medical. „Technologie und Dienstleistung gehören bei uns unbedingt zusammen. Sie zusammen machen erst eine erfolgreiche Therapie aus.“

Hintergrundinformationen „Schlafapnoe“
Mit Schlafapnoe werden nächtliche Atemstillstände bezeichnet. Betroffene können diese Atmungsaussetzer bis zu 400 Mal pro Nacht haben. Sie dauern häufig länger als zehn Sekunden. Ein erholsamer Schaf ist damit nicht mehr möglich. Die Folge: Die Betroffenen sind tagsüber müde, leiden unter Konzentrationsmangel und verminderter Leistungsfähigkeit und schlafen tagsüber mitunter unfreiwillig ein („Sekundenschlaf“).

Darüber hinaus leiden sie vermehrt unter Aggressivität oder Depression und haben ein erhöhtes Risiko für Herz-Kreislauf-Erkrankungen. Neuere Studien haben ergeben, dass Betroffene ein doppelt so hohes Risiko für einen Schlaganfall haben wie Vergleichpersonen ohne Störungen. Hinzu kommt, dass sie mehr Unfälle verursachen als Nicht-Betroffene. Die dadurch entstehenden volkswirtschaftlichen Kosten sind enorm.

Etwa 3 Millionen Menschen in Deutschland leiden unter dieser Krankheit. Schlafapnoe ist damit eine der meistverbreiteten Schlafstörungen. In der Altersgruppe von 30-60 Jahren geht man davon aus, dass 24% der Männer und 9% der Frauen betroffen sind. Dennoch sind nur 10% der Betroffenen in Behandlung.

Hintergrundinformationen Air Products Medical
Air Products Medical ist weltweit einer der führenden Anbieter medizinischer Gase und medizinisch-technischer Dienstleistungen. Als Homecare Unternehmen bietet Air Products Medical umfassende Versorgungs- und Therapiekonzepte für Patienten in der häuslichen Umgebung.

Hierzu zählen neben der Schlafapnoe-Therapie die Sauerstofflangzeit-Therapie, die Heim-Beatmung und die Patienten-Überwachung (Monitoring). Die Dienstleistung umfasst neben der Bereitstellung und Wartung der Medizintechnik-Geräte vor allem die Beratung, Betreuung und Schulung der Patienten und der pflegenden Angehörigen. Dazu gehört die Patienten-Überleitung aus dem Krankenhaus in die häusliche Umgebung genauso wie die gesamte Koordination und Abwicklung der Therapie mit der Krankenkasse oder Krankenversicherung.

Weltweit betreut Air Products Medical rund 300.000 Patienten. 150 Mitarbeiter versorgen in Deutschland über 50.000 Patienten. Damit gehört Air Products Medical nicht nur in Deutschland sondern weltweit zu den führenden Homecare-Unternehmen.

Air Products to Acquire Polish Industrial Gas Business from Linde

Mon, 08 Jan 2007 09:53:00 -0500

Air Products (NYSE:APD) today announced it has reached definitive agreement with The Linde Group to acquire the industrial gas business of BOC Gazy Sp z o.o. for 370 million euros ($481 million). The transaction is subject to regulatory approval and customary closing conditions. For regulatory purposes, BOC Gazy was required to be sold by Linde as a result of its purchase of The BOC Group plc in September 2006.

The BOC Gazy business had fiscal year 2006 sales of approximately 126 million euros ($164 million) and earnings before tax, interest, depreciation and amortization (EBITDA) of approximately 38 million euros ($50 million). The business has approximately 750 employees, five major industrial gas plants and six cylinder transfills serving customers across a diverse range of industries, including chemicals, steel and base metals, among others.

“We’re taking advantage of a unique opportunity to become the number one industrial gas supplier in Central Europe’s fastest growing economy,” said Air Products Chairman and Chief Executive Officer John Jones. “With manufacturing moving eastward in Europe and investment increasingly flowing in that direction, we intend to capitalize on the substantial growth potential in these markets. The business we are acquiring is very attractive and fits our strategy to become a higher growth and higher return company. It allows us to build critical mass and a low cost position in the region and be a bridge to serving a broad range of customers across Central and Eastern Europe.”

Air Products operates in 15 countries throughout Europe, including the central and eastern European countries of the Slovak Republic, the Czech Republic, Russia and Poland. Total European sales in Air Products’ 2006 fiscal year were approximately $2.6 billion. Within Poland, Air Products has been a supplier of industrial gases since the early 1990s and has annual sales of about 11 million euros ($15 million).

Air Products plans to finance the transaction through euro debt.

Air Products (NYSE:APD) serves customers in industrial, energy, technology and healthcare markets worldwide with a unique portfolio of atmospheric gases, process and specialty gases, performance materials, and equipment and services. Founded in 1940, Air Products has built leading positions in key growth markets such as semiconductor materials, refinery hydrogen, home healthcare services, natural gas liquefaction, and advanced coatings and adhesives. The company is recognized for its innovative culture, operational excellence and commitment to safety and the environment and is listed in the Dow Jones Sustainability and FTSE4Good Indices. The company has annual revenues of $9 billion, operations in over 40 countries, and over 20,000 employees around the globe. For more information, visit www.airproducts.com.

NOTE: This release contains “forward-looking statements” within the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. These forward-looking statements are based on management’s reasonable expectations and assumptions as of the date of this presentation regarding important risk factors. Actual performance and financial results may differ materially from those expressed in the forward-looking statements because of many factors, including those specifically referenced as future events or outcomes that the company anticipates as well as, among other things, overall economic and business conditions in Central and Eastern Europe and elsewhere different than those currently anticipated and demand for Air Products’ goods and services during that time; competitive factors in the industries in which it competes; natural or political interruption in ordinary sources of supply; the ability to recover unanticipated increased energy and raw material costs from customers; uninsured litigation judgments or settlements; changes in government regulations; consequences of acts of war or terrorism impacting the European and other markets; the effects of a pandemic or epidemic or a natural disaster; charges related to currently undetermined portfolio management and cost reduction actions; the success of implementing cost reduction programs or achieving synergies; the timing, impact, ability to complete and other uncertainties of future acquisitions or divestitures or unanticipated contract terminations; significant fluctuations in interest rates and foreign currencies from that currently anticipated; the impact of tax and other legislation and regulations in jurisdictions in which Air Products and its affiliates operate; the recovery of insurance proceeds; the impact of new financial accounting standards; and the timing and rate at which tax credits can be utilized. The company disclaims any obligation or undertaking to disseminate any updates or revisions to any forward-looking statements contained in this presentation to reflect any change in the company’s assumptions, beliefs or expectations or any change in events, conditions or circumstances upon which any such forward-looking statements are based.

Air Products' Membrane Manufacturing Facility Expanding to Meet Growing Demand

Thu, 07 Dec 2006 00:00:00 -0500

Air Products (NYSE: APD) today announced that it is doubling manufacturing capacity at its PRISM® membrane production plant in St. Louis, Mo. The 25,000 square foot building expansion project, expected to be on-stream in the summer of 2007, will provide the additional capacity to meet membrane product demand from several major market applications. Air Products currently produces approximately 20,000 membrane modules per year at the location.

The St. Louis facility produces advanced proprietary hollow fiber membranes which separate mixtures of gases by permeating molecules through membrane fibers at varied rates. For example, the PRISM membranes can separate compressed air -- oxygen from nitrogen -- to produce an inert nitrogen gas with 95 to 99.5 percent purity. In addition to generating nitrogen from compressed air, Air Products' membranes are also used to dry air and natural gas, and to recover for reuse industrial process gases such as hydrogen. Air Products' PRISM membranes have a wide array of applications ranging from producing gases to inert fuel tanks aboard aircraft, to use in coal mine methane recovery operations in China, for use in enriching oxygen for passengers on the world's longest and highest highland railway -- the Qinghai-Tibet railway, and to produce nitrogen for blanketing chemical, methanol and liquefied gas shipments around the globe.

"The expansion of the St. Louis plant ensures we can maintain our leadership and meet increasing requirements for membrane separators from our customers," said Charles Page, business manager for Air Products' PRISM Membrane division. "The expansion will support the tremendous worldwide growth in demand that we have experienced over the last two years across most of our major market segments."

Air Products markets robust, reliable gas separation equipment that is field-proven in a wide variety of applications. It has been operating at the St. Louis facility since 1984 and currently employs over 80 people. The production expansion has the potential to increase workforce levels by 30 to 45 positions. "We have a skilled workforce at St. Louis and are pleased to be expanding at a site where we've been manufacturing for over 20 years," Page said. "There is a favorable climate for business fostered by the Economic Council of St. Louis County and Missouri Department of Economic Development."

"We're delighted Air Products chose St. Louis County for its expansion," said St. Louis County Executive Charlie A. Dooley. "This is a great example of economic incentives making the difference in the retention and expansion of good jobs for our workers and residents."

Air Products (NYSE:APD) serves customers in industrial, energy, technology and healthcare markets worldwide with a unique portfolio of atmospheric gases, process and specialty gases, performance materials, and equipment and services. Founded in 1940, Air Products has built leading positions in key growth markets such as semiconductor materials, refinery hydrogen, home healthcare services, natural gas liquefaction, and advanced coatings and adhesives. The company is recognized for its innovative culture, operational excellence and commitment to safety and the environment and is listed in the Dow Jones Sustainability and FTSE4Good Indices. The company has annual revenues of $9 billion, operations in over 40 countries, and over 20,000 employees around the globe. For more information, visit www.airproducts.com.

NOTE: This release may contain forward-looking statements. Actual results could vary materially, due to changes in current expectations.

Air Products Announces North America Price Increase for Liquid-Bulk Oxygen, Nitrogen, Argon, Helium and Hydrogen

Tue, 19 Sep 2006 00:00:00 -0400

Effective October 1, 2006, or as contracts permit, Air Products (NYSE:APD) will increase schedule pricing on liquid-bulk oxygen, nitrogen, and hydrogen by 10 percent, and argon and helium by 20 percent for merchant and government customers in North America. Air Products also will be increasing its monthly service charge schedule pricing for storage and supply equipment, and eliminating discounts from schedule pricing for standard service offerings.

The pricing initiatives are needed to address escalating material, labor, and energy costs associated with the production and distribution of its merchant gas products, and to support capital investment required to meet current and future demand.

NOTE: This release may contain forward-looking statements. Actual results could vary materially, due to changes in current expectations.

Konkurencia Na Trhu Pomôže Slovenským Nemocniciam

Sun, 30 Jul 2006 00:00:00 -0400

Na slovenský trh medicinálnych plynov vstúpil ďalší hráč, americká spoločnosť Air Products, ktorá uviedla do prevádzky prvý zásobník medicinálneho kyslíka v Nemocnici Podunajské Biskupice pri Bratislave. Zásobník s kapacitou 11 m 3 zaistí prostredníctvom rúrkového rozvodu dodávku 70 tisíc litrov kyslíka ročne, čo tvorí asi 90 % z celkovej spotreby medicinálnych plynov v nemocnici.

„K tejto investícii a výmene dodávateľa nás v podstate prinútili prevádzkové dôvody a nutnosť preložiť odparovaciu stanicu na iné miesto v rámci areálu nemocnice,“ uvádza MUDr. Peter Kuka, riaditeľ nemocnice „Očakávame od nej zníženie nákladov na kyslík oproti predchádzajúcemu dodávateľovi a zvýšenie efektívnosti.“

Nemocnica Podunajské Biskupice lieči pacientov s pľúcnymi a kardiovaskulárnymi ochoreniami. Medicinálny kyslík používa hlavne na exygenoterapiu. Pri pľúcnych chorobách používa tiež pretlakové dýchanie kyslíkom alebo stlačeným vzduchom.

Spoločnosť Air Products je známa ako jeden z najväčších svetových výrobcov technických a medicinálnych plynov. V Spojených štátoch, Veľkej Británii alebo napríklad v Španielsku je dodávateľom kyslíka a potrebného technického vybavenia pre domácu oxygenoterapiu.

„Proces výberu a rozhodovania o investíciách v podmienkach finančného poddimenzovania v oblasti zdravotníctva je zvlášť namáhavý a citlivý,“ konštatuje ďalej riaditeľ. Kuka, „nakoľko musíme rozhodovať v obmedzenom priestore, musíme zohľadňovať nielen nákladovosť, ale aj vhodné finančné podmienky, čiže splácanie investície a podobne.“

„Slovenské zdravotníctvo je pre nás veľmi perspektívnym trhom, ktorému chceme pomôcť ponukou solídnych cien a kvalitných služieb,“ uvádza obchodný riaditeľ Air Products ČR a SR Martin Weiss.

„Rozšírila sa nám ponuka firiem. Tým sa nám naskytlo viacero možností výberu a možná regulácia cien v rámci trhového prostredia. Nakoľko je tok financií do nemocnice obmedzený, je nevyhnutné, aby každý zdravotnícky pracovník rozmýšľal ekonomicky, aby bola efektivita liečby najvyššia pri čo najnižších nákladoch“, doplňuje riaditeľ nemocnice.

„Naše produkty spĺňajú najvyššie kvalitatívne a bezpečnostné štandardy vyhovujúce legislatíve Európskej únie aj Spojených štátov,“ uzatvára obchodný riaditeľ Air Products ČR a SR Martin Weiss. Firma je zatiaľ jediným dodávateľom medicinálnych plynov, ktorý spĺňa podmienky novej slovenskej legislatívy vyžadujúcej povolenie Ministerstva zdravotníctva SR (podľa Zákona NR SR č. 140/1998 Z. z.).

Spoločnosť Air Products Česká a Slovenská republika je súčasťou medzinárodného koncernu Air Products and Chemicals, Inc., so sídlom v USA. Koncern bol založený v roku 1940, v súčasnej dobe zamestnáva 20 200 ľudí v 30 krajinách sveta. Ročný obrat prevyšuje 8,14 miliardy dolárov. Zaujímavosťou je, že Air Products dodáva technický kyslík a vodík ako palivo pre raketoplány amerického kozmického programu NASA.

Kyslík Air Products v moderní genetice

Tue, 30 May 2006 00:00:00 -0400

Společnost Air Products, známá odborné veřejnosti především jako výrobce a dodavatel technických plynů, vstoupila v roce 2005 i na pole jednoho z nejmodernějších oborů současného lékařství – genetiky.

Asi pět procent novorozenců je postiženo vrozenou vadou. Jednou z nejčastějších vrozených genetických vad je Downův syndrom. Metodami moderní genetiky lze často identifikovat vrozenou vadu již v těhotenství (prenatální diagnostika) a umožnit budoucím rodičům svobodu volby, zda přivést na svět postižené dítě.

Preimplantační diagnostika dokonce umožňuje v programu asistované reprodukce geneticky vyšetřovat zárodky ještě před vložením do dělohy a vyřadit ty, jež jsou ohroženy genetickou vadou. Genetická prenatální vyšetření se provádějí většinou do 24. týdne těhotenství.

Jedním z předních soukromých pracovišť je Centrum lékařské genetiky a reprodukční medicíny Gennet, s. r. o., v Praze. Z celkového počtu 14 228 ošetřených rodin za rok 2005 centrum diagnostikovalo na 200 vrozených vad. Z toho zhruba polovina případů vedla k přerušení těhotenství.

„Těhotenská genetika má významný společenský rozměr,“ podtrhuje vedoucí lékař a spolumajitel MUDr. David Stejskal důležitost podobných pracovišť. Genetika podporuje celosvětový trend plánovaného rodičovství. U rodičovských párů posiluje odpovědnost a umožňuje jim tuto odpovědnost realizovat. Tím přispívá k celkovému zvyšování kvality života. Jedinou stinnou stránkou věci je, že posilování podobné odpovědnosti spoluvytváří mylný dojem, že moderní vědou dokážeme ovlivnit všechno. To ovšem není pravda, jak poznamenává dr. Stejskal.

Četnost genetických problémů v těhotenství je poměrně vysoká. Uvádí se, že zhruba 10 % těhotných žen u nás by potřebovalo genetickou konzultaci. Rozšiřuje se riziková skupina žen rodících ve věku nad 35 let, v současnosti je jich asi 8 %. Asi 16 % rodiček podstupuje odběr plodové vody a genetické vyšetření.

Současná medicína nedokáže opravit poškozený gen. Pokud to vůbec kdy bude možné, pak je to otázka spíše vzdálené budoucnosti. V každém případě je nesporným přínosem včas zjištěných vad plodu fakt, že rodička má právo těhotenství ukončit, pokud se prokáže poškození plodu. Nerozhodne-li se rodina k potratu, může se aktivně připravovat na příchod ohroženého dítěte.

Poskytovatel špičkových lékařských služeb se neobejde bez špičkových služeb dodavatele jednoho ze základních podpůrných prvků při vyšetřeních a léčbě, kterým jsou medicinální plyny. Bez nich by nebylo možno tuto lékařskou disciplínu vůbec provozovat.

„Atmosféra složená z čistého kyslíku s 5% obsahem CO2 slouží ke kultivaci buněk pro genetická vyšetření a zárodků v programu asistované reprodukce,“ uvádí MUDr. Stejskal. Medicinální kyslík a oxid dusný se také používá při anestezii u malých operačních výkonů.

Bez medicinálního oxidu uhličitého a medicinálního vzduchu by nebylo možné provádět kultivace tkání pro genetická vyšetření a zárodků v programu asistované reprodukce.

Gennet je v oblasti medicinálních plynů prestižním klientem Air Products od roku 2005. „Když potřebuji závoz plynu, mám jej zde okamžitě a s plným servisem. S předcházejícím dodavatelem jsem byl hrubě nespokojen,“ vysvětluje rozhodnutí o volbě nového dodavatele medicinálních plynů čímž je Air Products, jednatel JUDr. Matěj Stejskal.

Air Products Announces Surcharge for U.S. Merchant Customers

Mon, 22 May 2006 00:00:00 -0400

Air Products (NYSE:APD) announced today that it is increasing nationwide surcharges on its liquid oxygen and liquid nitrogen products starting June 1, 2006. The surcharges are required to recover increased distribution costs such as purchased transportation and diesel fuel.

NOTE: This release may contain forward-looking statements. Actual results could vary materially, due to changes in current expectations.